Visual disturbances

H7_VISUDISTURB

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H53 Cause of death: ICD-10 — H53 2 out of 7 registries used, show all original rules.	28439
4. Check minimum number of events None	28439
5. Include endpoints H7_AMBLYANOPSIA H7_VISUDISTURBSUB H7_DIPLOPIA H7_BINODISTOTH H7_VISFIELDDEF H7_COULOURVISDEF H7_NIGHTBLIND H7_VISDISTNAS	28908
6. Filter based on genotype QC (FinnGen only)	26126

Control definitions (FinnGen only)

Control exclude: H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H53-H54
Name in latin: Perturbationes visus

NAME	H7_VISUDISTURB
CONTROL_EXCLUDE	H7_VISUALDISTBLIND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_AMBLYANOPSIA\|H7_VISUDISTURBSUB\|H7_DIPLOPIA\|H7_BINODISTOTH\|H7_VISFIELDDEF\|H7_COULOURVISDEF\|H7_NIGHTBLIND\|H7_VISDISTNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H53
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H53
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Visual disturbances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	163178	89574	72973
Only index persons	148634	83120	65514
Unadjusted period prevalence (%)
Whole population	2.32	2.57	2.04
Only index persons	2.81	3.06	2.50
Median age at first event (years)
Whole population	50.72	51.69	49.53
Only index persons	51.91	52.72	50.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	26126	16129	9997
Unadjusted period prevalence (%)	5.29	5.73	4.58
Median age at first event (years)	59.31	57.14	62.80

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
27030: Matched controls
270299

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.0

ICD-10 Finland

Dyspnoea

1.7

323.0

7604

49846

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

313.2

4251

23503

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

12.8

311.4

301

237

A02BC02

ATC

pantoprazole; systemic

1.7

307.7

18357

150607

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.8

307.7

3879

11495

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.6

307.7

3145

9591

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

13942

95563

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.2

307.7

1742

4348

H53.3

ICD-10 Finland

Other disorders of binocular vision

42.4

307.7

597

144

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

26.5

307.7

276

105

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.2

307.7

7460

29015

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

307.7

11955

84634

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

3.5

307.7

3238

10118

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.1

307.7

1422

3578

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

8210

51414

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

307.7

10449

73696

B01AC04

ATC

clopidogrel; oral

2.2

307.7

4751

24335

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

307.7

2544

10146

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.8

307.7

1886

5293

TAB00

NOMESCO Finland

Lumbar puncture

3.4

307.7

1685

5169

XCK00

NOMESCO Finland

Perimetry

5.6

307.7

3444

6924

H50.52

ICD-10 Finland

Exophoria

6.4

307.7

598

946

F05

ICPC

Visual disturbance other

5.6

307.7

1828

3459

CS494

NOMESCO Finland

Other visual field testing

4.5

307.7

1092

2498

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

307.7

2608

9188

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

14.3

307.7

389

276

AA1AD

NOMESCO Finland

CT of head and brain

3.4

307.7

11680

50008

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

10.7

307.7

539

514

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.8

307.7

3452

13347

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.4

307.7

4020

13168

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

307.7

3405

13008

PA6AD

NOMESCO Finland

CT of neck arteries

4.5

307.7

1731

4091

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

15.1

307.7

627

425

G45.3

ICD-10 Finland

Amaurosis fugax

8.6

307.7

1204

1451

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.8

307.7

3133

11975

H53.2

ICD-10 Finland

Diplopia

155.4

307.7

6156

512

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

7343

47642

H53.0

ICD-10 Finland

Amblyopia ex anopsia

122.3

307.7

1458

126

H53.8

ICD-10 Finland

Other visual disturbances

17.6

307.7

1329

794

H50.2

ICD-10 Finland

Vertical strabismus

8.8

307.7

420

486

H50.0

ICD-10 Finland

Convergent concomitant strabismus

9.3

307.7

426

465

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

3.2

307.7

2430

8194

G44.2

ICD-10 Finland

Tension-type headache

2.2

307.7

4422

22420

H53.9

ICD-10 Finland

Visual disturbance, unspecified

23.1

307.7

4860

2543

R42

ICD-10 Finland

Dizziness and giddiness

2.3

307.7

7848

41412

H53.1

ICD-10 Finland

Subjective visual disturbances

75.9

307.7

13403

3460

H46

ICD-10 Finland

Optic neuritis

9.8

307.7

509

529

M79.6

ICD-10 Finland

Pain in limb

1.7

307.7

12356

90824

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.7

307.7

4737

14801

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

4.3

307.7

1582

3860

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.8

307.7

1790

6594

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.6

307.7

4235

13265

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.5

307.7

1402

3261

XA800

NOMESCO Finland

Neuropsychological investigation

3.1

307.7

1472

4911

R51.80

ICD-10 Finland

Headache

2.8

307.7

6138

25855

H53.4

ICD-10 Finland

Visual field defects

188.0

307.7

3801

235

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

307.7

3836

18910

H53.5

ICD-10 Finland

Colour vision deficiencies

45.9

303.3

178

N17

ICPC

Vertigo/dizziness

2.0

300.3

3907

21264

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.9

298.5

915

2425

N03AX12

ATC

[U] gabapentin; oral

1.9

295.8

4482

25659

F29

ICPC

Eye symptom/complaint other

2.1

295.2

3311

17081

G35

ICD-10 Finland

Multiple sclerosis

4.9

292.4

659

1379

N03AX16

ATC

[U] pregabalin

1.7

287.5

6186

39329

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.9

283.1

842

2184

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

282.6

7840

53322

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

281.8

1956

8268

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

4.3

281.2

749

1791

CE2W4

NOMESCO Finland

Eye movement mapping

27.1

273.4

186

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

7.6

271.2

386

515

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

267.0

3731

20738

H57.1

ICD-10 Finland

Ocular pain

2.9

264.4

1338

4827

Z3231

NOMESCO Finland

Registered nurse

1.7

262.9

7271

49237

N01

ICPC

Headache

2.0

262.1

3496

19123

A02BC05

ATC

esomeprazole; systemic

1.6

259.1

10635

79090

C07AB07

ATC

bisoprolol; oral

1.5

256.6

12306

94695

109

Kela drug reimbursment

Multiple sclerosis

5.5

253.6

492

902

N02AX02

ATC

tramadol; systemic, rectal

1.6

252.5

11142

84067

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

252.2

6294

41432

M54.5

ICD-10 Finland

Low back pain

1.6

250.0

9880

72675

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

+∞

247.2

237

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

247.0

5049

31462

H50.1

ICD-10 Finland

Divergent concomitant strabismus

7.1

246.1

373

534

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.9

245.2

442

756

C10AA05

ATC

atorvastatin; oral

1.5

243.6

10665

80132

H47.2

ICD-10 Finland

Optic atrophy

12.1

243.0

243

202

L17

ICPC

Foot/toe symptom/complaint

1.6

239.1

8436

60312

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

6.1

237.6

417

695

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

236.1

2570

13053

H53

ICD-10 Finland

Visual disturbances

5.9

233.8

420

716

N06AX11

ATC

mirtazapine; oral

1.6

232.2

9037

65962

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

231.2

1835

8213

R02

ICPC

Shortness of breath/dyspnoea

1.8

229.0

3902

23005

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

226.6

6510

44217

N03AX09

ATC

lamotrigine; oral

2.5

225.0

1453

5922

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

222.8

3482

19979

H51.1

ICD-10 Finland

Convergence insufficiency and excess

12.1

222.5

223

186

R03AC02

ATC

salbutamol; inhalant

1.5

220.7

14415

116946

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.4

220.2

829

2515

H02AB06

ATC

prednisolone; systemic

1.5

218.9

12321

96906

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

218.3

2695

14300

N02BE01

ATC

paracetamol; systemic, rectal

1.8

216.3

23837

217106

ZXA10

NOMESCO Finland

Bilateral

1.7

210.2

4806

30720

H50.31

ICD-10 Finland

Intermittent exotropia

5.9

209.9

381

656

R07.3

ICD-10 Finland

Other chest pain

1.9

205.9

2888

15980

L03

ICPC

Low back symptom/complaint

1.5

205.7

7869

56867

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.2

204.9

556

1347

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

204.9

4605

29280

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

6.8

204.1

319

472

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

203.9

4237

26371

L01

ICPC

Neck symptom/complaint

1.7

203.1

4497

28470

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

4.1

203.0

572

1425

M25.5

ICD-10 Finland

Pain in joint

1.5

202.9

8623

63700

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

201.3

5770

38993

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.8

200.4

1085

4048

S18

ICPC

Laceration/cut

1.5

200.1

12227

97124

H50.30

ICD-10 Finland

Intermittent esotropy

8.4

196.4

255

305

A04

ICPC

Weakness/tiredness general

1.7

196.3

4489

28636

A11

ICPC

Chest pain NOS

2.0

196.1

2436

12929

H54.7

ICD-10 Finland

Unspecified visual loss

7.7

195.6

273

356

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

190.0

6788

48161

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

189.7

5898

40547

C07AA05

ATC

propranolol; systemic

1.6

189.6

5193

34641

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

189.4

2237

11659

R52.9

ICD-10 Finland

Pain, unspecified

1.8

187.7

2933

16767

M03BX02

ATC

tizanidine; oral

1.5

187.5

15702

131789

N06AX21

ATC

duloxetine; oral

1.8

187.2

3217

18929

M79.1

ICD-10 Finland

Myalgia

1.7

186.8

4029

25272

Z71.8

ICD-10 Finland

Other specified counselling

1.5

186.8

9106

68897

XCH00

NOMESCO Finland

Eye pressure measurement

2.4

185.0

1388

6048

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

184.4

1556

7129

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

182.9

10841

85109

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

181.7

4573

29836

S06.0

ICD-10 Finland

Concussion

1.8

181.4

2964

17166

A01

ICPC

Pain general/multiple sites

1.8

181.3

2826

16134

R4120

NOMESCO Finland

Occupational therapy

2.1

180.9

1811

8879

D01

ICPC

Abdominal pain/cramps general

1.7

180.4

3516

21434

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.9

179.1

846

2932

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

178.7

11020

87041

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.2

178.5

747

2415

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

6.2

177.9

307

503

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

176.5

4801

31905

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

174.8

18740

163674

R4110

NOMESCO Finland

Physiotherapy

1.5

174.5

7018

50903

H50.51

ICD-10 Finland

Esophoria

8.0

173.0

235

297

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

172.4

1953

10017

H26.4

ICD-10 Finland

After-cataract

1.8

172.1

2616

14805

J01DB01

ATC

cefalexin; oral

1.6

172.1

21727

195857

R13

ICD-10 Finland

Dysphagia

2.0

171.7

1915

9767

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

171.2

14078

116846

XF404

NOMESCO Finland

Ambulatory ECG

1.9

170.2

2236

12071

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

169.4

6443

46133

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

169.4

3661

22925

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.6

168.1

980

3793

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

167.0

2795

16281

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

167.0

2640

15116

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

164.4

3436

21309

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

164.2

3482

21679

Z2221

NOMESCO Finland

Medical doctor

1.5

163.4

6796

49510

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

163.2

4707

31649

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

162.8

10906

86972

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

162.6

18704

164181

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

5.9

161.7

294

507

N05BA04

ATC

oxazepam; oral

1.5

161.1

6604

47941

A02BC03

ATC

lansoprazole; oral

1.5

160.4

6900

50578

UJF32

NOMESCO Finland

Coloscopy

1.5

160.2

6513

47193

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.9

159.9

2188

11961

N03AG01

ATC

valproic acid; systemic, rectal

2.1

159.8

1566

7606

WX002

NOMESCO Finland

Sedation and analgesia

1.6

159.7

4702

31752

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

159.0

4129

27056

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

159.0

7469

55692

Z3226

NOMESCO Finland

Physiotherapist

1.6

158.4

4462

29813

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

158.1

7531

56293

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

157.5

3401

21260

N06AX16

ATC

venlafaxine; oral

1.7

157.3

3621

23015

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

157.0

9971

78605

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

156.8

4785

32562

J01AA02

ATC

doxycycline; systemic

1.5

155.6

19609

174201

R51

ICD-10 Finland

Headache

2.1

155.6

1604

7939

B01AA03

ATC

warfarin; systemic

1.6

155.5

4223

27960

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

155.1

12918

106687

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

154.6

5242

36508

R55

ICD-10 Finland

Syncope and collapse

1.7

154.0

2846

17039

L12

ICPC

Hand/finger symptom/complaint

1.6

153.9

4596

31105

WX140

NOMESCO Finland

Parabulbar anesthesy

2.3

153.3

1236

5548

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

153.1

7858

59501

N02BF01

ATC

gabapentin; oral

1.8

152.7

2766

16464

L28

ICPC

Limited function/disability (L)

1.6

152.4

4775

32667

D06

ICPC

Abdominal pain localized other

1.8

152.2

2537

14739

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

152.1

7974

60608

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.2

151.3

1379

6508

R05

ICPC

Cough

1.5

151.2

6563

48088

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

151.1

1593

7948

H54.4

ICD-10 Finland

Blindness, monocular

25.1

150.0

105

R01AD09

ATC

mometasone; nasal

1.4

147.8

11389

92543

N03AF02

ATC

oxcarbazepine; oral

2.5

147.4

925

3709

H52.0

ICD-10 Finland

Hypermetropia

3.0

147.1

660

2221

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.5

146.4

503

1438

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

6.3

146.2

245

390

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

145.9

5605

40018

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

145.2

11591

94648

R00.2

ICD-10 Finland

Palpitations

1.9

145.0

2157

12096

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

144.9

2735

16455

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

4.2

144.5

386

924

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

143.9

4805

33285

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

143.6

1593

8094

Z2445

NOMESCO Finland

Psychologist

2.3

143.5

1080

4705

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

8.3

143.2

188

228

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

143.0

3154

19788

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

6.8

142.3

223

331

S29

ICPC

Skin symptom/complaint other

1.5

141.2

5331

37891

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.9

140.5

679

2381

N03AX14

ATC

levetiracetam; systemic

2.6

140.3

832

3245

H34.2

ICD-10 Finland

Other retinal artery occlusions

6.5

140.2

229

355

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

140.0

8276

64066

K80

ICPC

Cardiac arrhythmia NOS

1.8

139.4

2269

13072

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

137.1

8485

66157

A02BC01

ATC

omeprazole; systemic

1.5

136.9

6600

49185

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

136.8

3302

21181

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

136.4

7670

58790

CEC00

NOMESCO Finland

Recession of extraocular muscle

7.4

136.1

198

271

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.6

136.0

3484

22676

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

136.0

6315

46718

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

135.6

4765

33323

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

134.2

8992

71009

N07AA02

ATC

pyridostigmine; systemic

6.5

134.0

220

343

ZXA05

NOMESCO Finland

Left side

1.5

133.9

5709

41519

CKC12

NOMESCO Finland

Photocoagulation of retina

2.3

133.4

1102

4993

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.1

133.2

554

1784

G47.3

ICD-10 Finland

Sleep apnoea

1.5

132.9

5452

39341

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

10.5

132.8

146

140

R52.2

ICD-10 Finland

Other chronic pain

2.3

132.6

1035

4578

N05AH04

ATC

quetiapine; oral

1.5

132.6

4323

29731

K90

ICPC

Stroke/cerebrovascular accident

2.6

132.1

777

3018

H52.2

ICD-10 Finland

Astigmatism

3.1

132.0

574

1897

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

131.9

6274

46580

XF402

NOMESCO Finland

ECG with work load test

1.7

131.8

2487

14941

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

131.4

3147

20135

G70.0

ICD-10 Finland

Myasthenia gravis

7.5

131.2

187

250

H47.1

ICD-10 Finland

Papilloedema, unspecified

5.9

130.6

234

398

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

130.4

2470

14854

C10AX09

ATC

ezetimibe; oral

1.6

130.1

4054

27594

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

3.0

130.0

573

1908

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.9

129.7

642

2281

K30

ICD-10 Finland

Functional dyspepsia

1.7

129.4

2933

18500

J01MA02

ATC

ciprofloxacin; systemic

1.4

129.4

9319

74367

R50.9

ICD-10 Finland

Fever, unspecified

1.6

129.2

3820

25691

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

129.2

5325

38432

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

4.1

128.8

352

857

R11

ICD-10 Finland

Nausea and vomiting

1.8

128.1

2307

13673

P01AB01

ATC

metronidazole; oral, rectal

1.4

128.0

9770

78667

N03AE01

ATC

clonazepam; systemic

2.0

127.2

1406

7127

C09CA06

ATC

candesartan; oral

1.5

125.9

5910

43702

H33.0

ICD-10 Finland

Retinal detachment with retinal break

2.6

125.9

737

2855

N05CF01

ATC

zopiclone; oral

1.4

125.2

7600

58847

G43.8

ICD-10 Finland

Other migraine

3.3

124.9

487

1508

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

123.7

2924

18628

J01FA10

ATC

azithromycin; systemic

1.4

122.8

14345

123121

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

6.8

122.5

192

285

N06AB04

ATC

citalopram; systemic

1.5

122.2

4910

35206

J01CA04

ATC

amoxicillin; systemic

1.4

121.4

21221

194089

G43.3

ICD-10 Finland

Complicated migraine

3.1

121.4

518

1693

E23.00

ICD-10 Finland

Panhypopituitarism

7.1

121.2

183

261

J01FA06

ATC

roxithromycin; oral

1.4

121.2

9355

75274

A28

ICPC

Limited function/disability NOS

1.5

121.0

4211

29309

H02AB09

ATC

hydrocortisone; systemic

2.7

120.2

679

2584

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

7.5

119.4

171

230

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

117.9

4707

33678

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

117.7

13075

111069

H52.1

ICD-10 Finland

Myopia

2.2

117.2

989

4518

M54.2

ICD-10 Finland

Cervicalgia

1.8

117.1

2037

11943

L03AX13

ATC

glatiramer acetate; parenteral

6.5

117.0

191

296

N06AB10

ATC

escitalopram; oral

1.5

116.7

5009

36341

Z01.2

ICD-10 Finland

Dental examination

1.3

116.7

11865

99424

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.8

116.5

589

2116

R21

ICPC

Throat symptom/complaint

1.4

115.9

5450

40219

A02BA02

ATC

ranitidine; systemic

1.5

115.8

4321

30485

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

114.7

6776

52066

L03AB07

ATC

interferon beta-1a; parenteral

5.6

114.6

219

396

UKC02

NOMESCO Finland

Cystoscopy

1.5

114.5

3606

24537

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

114.3

5991

45080

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.0

113.9

325

817

ZXA00

NOMESCO Finland

Right side

1.4

113.9

5987

45065

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

113.9

2520

15768

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

+∞

113.6

109

SPAT1263

SPAT

Sampling

1.3

113.5

10293

84660

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

113.3

2555

16065

N05BA01

ATC

diazepam; systemic, rectal

1.6

113.0

2999

19623

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

112.7

3416

23041

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

112.6

4752

34332

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

112.3

2308

14163

SFA10

NOMESCO Finland

One-surface restoration

1.3

112.3

13821

118840

S21

ICPC

Skin texture symptom/complaint

1.5

112.3

3858

26739

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.7

112.2

2090

12485

N03AX11

ATC

topiramate; oral

2.6

111.9

664

2589

R06AE07

ATC

cetirizine; oral

1.3

111.1

10848

90123

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

110.1

1213

6135

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

4.1

110.1

303

742

G81.9

ICD-10 Finland

Hemiplegia, unspecified

4.0

109.8

315

795

L08

ICPC

Shoulder symptom/complaint

1.4

109.6

5625

42118

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

6.8

109.5

171

253

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

109.2

4375

31266

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

109.2

17066

151625

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

108.9

2424

15180

R60.0

ICD-10 Finland

Localized oedema

1.6

108.6

3101

20623

ZXE00

NOMESCO Finland

One hour or less

1.3

108.5

9201

74771

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.6

108.4

650

2547

Z2446

NOMESCO Finland

Social worker

1.9

108.2

1564

8665

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.9

108.1

530

1873

H54.5

ICD-10 Finland

Severe visual impairment, monocular

6.7

107.9

171

257

L04

ICPC

Chest symptom/complaint

1.8

107.9

1669

9444

N30.0

ICD-10 Finland

Acute cystitis

1.5

107.6

4381

31400

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

107.5

1379

7352

WX892

NOMESCO Finland

Monitored bed care

1.8

106.6

1824

10632

SPAT1301

SPAT

No procedures

1.4

106.6

7581

59909

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

106.6

838

3715

K02.1

ICD-10 Finland

Caries of dentine

1.3

106.0

14766

128745

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

105.9

2432

15347

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.4

105.7

379

1114

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

105.4

1140

5727

C03CA01

ATC

furosemide; systemic

1.4

105.3

6734

52294

M03BX01

ATC

baclofen; systemic

2.9

105.2

512

1802

R4150

NOMESCO Finland

Neuropsychological rehabilitation

4.5

105.0

258

579

J02AC01

ATC

fluconazole; systemic

1.3

104.9

9475

77617

R74

ICPC

Upper respiratory infection acute

1.4

104.8

8213

65851

ZXD05

NOMESCO Finland

Urgent procedure

1.4

104.7

6990

54653

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

104.6

1623

9190

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

104.3

3440

23605

SFA20

NOMESCO Finland

Two-surface restoration

1.3

103.9

14426

125561

E0000UV, ,

ATC

1.3

103.8

10362

86084

R03DC03

ATC

montelukast; oral

1.5

103.4

3964

28050

C08CA01

ATC

amlodipine; oral

1.3

103.0

8905

72418

H02.4

ICD-10 Finland

Ptosis of eyelid

2.3

102.5

779

3403

J01FF01

ATC

clindamycin; systemic

1.4

102.5

6316

48709

K07.60

ICD-10 Finland

Snapping jaw

1.9

102.3

1311

6985

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

102.1

2347

14807

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

101.7

1581

8955

U02

ICPC

Urinary frequency/urgency

1.5

100.8

3760

26448

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

100.7

2140

13231

R05

ICD-10 Finland

Cough

1.4

100.4

5272

39541

D11

ICPC

Diarrhoea

1.6

100.4

3005

20174

108

Kela drug reimbursment

Myasthenia gravis

7.5

99.6

142

190

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

3.4

99.1

354

1038

C10AA07

ATC

rosuvastatin; oral

1.3

99.0

7831

62750

G93.2

ICD-10 Finland

Benign intracranial hypertension

8.7

98.7

125

145

G50.1

ICD-10 Finland

Atypical facial pain

2.8

98.7

505

1826

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

98.5

5978

45936

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.9

98.3

1292

6940

X58

ICD-10 Finland

Exposure to other specified factors

1.5

98.2

3568

24953

C07AB02

ATC

metoprolol; systemic

1.4

98.1

4381

31895

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

98.1

9198

75549

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

97.9

2906

19468

K89

ICPC

Transient cerebral ischaemia

3.7

97.8

314

858

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

4.0

97.4

279

704

N89

ICPC

Migraine

2.1

97.2

943

4549

J01DA01

ATC

[U] cefalexin

1.3

97.1

14838

130284

R51.81

ICD-10 Finland

Facial pain NOS

2.5

97.1

646

2660

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

96.8

861

4015

C01DA14

ATC

isosorbide mononitrate; oral

1.5

96.8

3223

22133

H34.1

ICD-10 Finland

Central retinal artery occlusion

5.4

96.7

192

360

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

96.3

8367

67925

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

96.2

14407

126078

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.7

96.1

307

836

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

95.8

9983

83154

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

95.7

1352

7430

M01AE02

ATC

naproxen; oral, rectal

1.3

95.5

13801

120148

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

95.3

1928

11762

164

Kela drug reimbursment

Fingolimod

7.2

95.2

140

194

C10AA01

ATC

simvastatin; oral

1.3

95.1

9209

75894

SPAT1260

SPAT

Consultation of another employee

1.4

94.8

4189

30416

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

94.2

2426

15723

N06AB06

ATC

sertraline; oral

1.6

93.8

2694

17905

N86

ICPC

Multiple sclerosis

4.5

93.7

229

512

H29

ICPC

Ear symptom/complaint other

1.5

93.5

3000

20427

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

93.4

2834

19063

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

93.3

1684

9955

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

92.8

1882

11485

L04AX07

ATC

dimethyl fumarate; oral

6.4

92.6

152

237

H03AA01

ATC

levothyroxine sodium; systemic

1.4

92.5

5486

41922

H01

ICPC

Ear pain/earache

1.5

92.3

3003

20504

A29

ICPC

General symptom/complaint other

1.5

92.3

3268

22713

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

92.1

5144

38912

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.3

91.8

358

1109

KMAK, ,

NOMESCO Finland

1.3

91.7

12101

103855

SPAT1097

SPAT

Recording of ECG

1.5

91.6

3274

22793

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

91.6

2216

14140

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.1

91.6

255

630

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

91.2

1824

11088

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

90.6

2483

16318

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

89.5

1140

6056

U07

ICPC

Urine symptom/complaint other

1.6

89.5

2112

13394

R01AD08

ATC

fluticasone; nasal

1.3

89.4

6654

52664

K04

ICPC

Palpitations/awareness of heart

1.8

89.3

1341

7509

A03

ICPC

Fever

1.4

89.2

4249

31243

H93.1

ICD-10 Finland

Tinnitus

1.7

89.0

1674

10007

L02

ICPC

Back symptom/complaint

1.6

88.8

2564

17048

D02

ICPC

Abdominal pain epigastric

1.7

88.8

1590

9376

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

88.4

1178

6353

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.6

88.3

299

847

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

87.9

3114

21629

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

87.8

3686

26472

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

87.8

3861

27972

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

87.7

4491

33435

H52.5

ICD-10 Finland

Disorders of accommodation

8.5

87.7

113

134

R01AD58

ATC

fluticasone, combinations; nasal

1.4

87.7

5924

46166

P06

ICPC

Sleep disturbance

1.5

87.4

3118

21684

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.8

87.4

270

719

P20

ICPC

Memory disturbance

1.5

87.3

3141

21882

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

87.2

2400

15781

A97

ICPC

No disease

1.4

87.2

4968

37663

H25.0

ICD-10 Finland

Senile incipient cataract

1.8

87.0

1509

8817

B01AC07

ATC

dipyridamole; systemic

2.1

86.8

835

4013

D07AC01

ATC

betamethasone; topical

1.3

86.8

8625

71099

-1, ,

NOMESCO Finland

1.3

86.7

7862

63981

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

86.0

1010

5219

N06AB03

ATC

fluoxetine; oral

1.5

86.0

2792

19037

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.1

85.9

366

1196

J05AB01

ATC

aciclovir; systemic

1.4

85.8

5106

38975

R06AX27

ATC

desloratadine; oral

1.3

85.7

6861

54826

A98

ICPC

Health maint/preventive medicine

1.8

85.6

25817

249221

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

85.3

1524

8978

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

85.3

2125

13649

N06AA09

ATC

amitriptyline; systemic

1.6

85.0

2122

13634

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

84.7

6108

48043

R03BA02

ATC

budesonide; inhalant

1.4

84.2

4167

30817

B01AB05

ATC

enoxaparin; parenteral

1.3

83.7

7300

59019

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

83.7

2485

16615

K08.80

ICD-10 Finland

Toothache NOS

1.6

83.7

2177

14124

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

83.4

6932

55655

ZY010

NOMESCO Finland

Hospital outpatient

1.8

83.3

1225

6813

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

83.0

5185

39861

L15

ICPC

Knee symptom/complaint

1.3

83.0

6097

48065

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.7

82.9

1663

10111

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

82.8

3897

28554

L13

ICPC

Hip symptom/complaint

1.4

82.7

4609

34774

101

Kela drug reimbursment

Anterior pituitary hypofunction

4.3

82.7

216

509

M01AB05

ATC

diclofenac; systemic, rectal

1.3

82.6

15803

141376

H40.0

ICD-10 Finland

Glaucoma suspect

1.6

82.5

1834

11450

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

82.2

5156

39655

R07.0

ICD-10 Finland

Pain in throat

1.7

81.9

1789

11119

L29

ICPC

Musculoskeletal sympt/complt other

1.6

81.7

2178

14206

353

Kela drug reimbursment

Cladribine and fingolimod

6.9

81.7

125

181

H02AB04

ATC

methylprednisolone; systemic

1.5

81.7

3237

22963

R12

ICD-10 Finland

Heartburn

1.6

81.7

2041

13113

SPAT1310

SPAT

Counselling related to known health issue

1.3

81.6

7483

60877

SFA30

NOMESCO Finland

Three-surface restoration

1.3

81.5

9901

83624

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

81.4

3336

23820

N02BF02

ATC

pregabalin; oral

1.7

81.0

1636

9962

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

80.9

2540

17183

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

80.8

2012

12913

H02

ICPC

Hearing complaint

1.4

80.7

3424

24605

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.2

80.6

327

1038

WX402

NOMESCO Finland

General anaesthesia

1.4

80.6

5293

40985

R04.0

ICD-10 Finland

Epistaxis

1.7

80.5

1707

10527

L05

ICPC

Flank/axilla symptom/complaint

1.7

80.4

1539

9236

H02AB07

ATC

prednisone; oral

1.5

80.4

2996

20995

R4110, ,

SPAT

1.5

79.8

3183

22604

B01AF02

ATC

apixaban; oral

1.5

79.5

3018

21224

H50.9

ICD-10 Finland

Strabismus, unspecified

6.7

79.3

125

187

P01

ICPC

Feeling anxious/nervous/tense

1.5

79.1

3081

21775

F01

ICPC

Eye pain

2.1

79.0

783

3805

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

79.0

1974

12678

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

79.0

836

4163

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

79.0

3984

29526

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

78.9

1107

6066

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

78.8

2777

19238

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

78.8

2317

15447

R03BA05

ATC

fluticasone; inhalant

1.4

78.8

4215

31553

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

78.7

6509

52133

A99

ICPC

Disease/condition unspecnature/site

1.5

78.6

2510

17035

XQ800

NOMESCO Finland

Prick test

1.7

78.6

1689

10450

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

4.6

78.5

184

398

L04AA27

ATC

[U] fingolimod

8.3

78.5

103

125

C01CA24

ATC

epinephrine; parenteral

1.7

78.0

1438

8540

H54.1

ICD-10 Finland

Severe visual impairment, binocular

23.4

77.8

PA2AD

NOMESCO Finland

CT angiography of brain

3.4

77.7

281

831

N03AF01

ATC

carbamazepine; oral, rectal

1.9

77.6

1089

5966

SPAT1216

SPAT

Assessment of functional ability

1.4

77.6

3435

24866

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

77.3

2448

16582

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.0

77.2

817

4069

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

77.1

2895

20306

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

76.9

1345

7870

R03BA08

ATC

ciclesonide; inhalant

1.6

76.8

2012

13062

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

76.8

3742

27550

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

76.8

2024

13159

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.3

76.7

598

2641

N18

ICPC

Paralysis/weakness

2.5

76.7

489

1974

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

76.7

687

3212

R96

ICPC

Asthma

1.5

76.5

2358

15877

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.0

76.5

217

544

WX290

NOMESCO Finland

Other blockage of nerve

1.3

76.0

11323

97814

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

75.9

491

1996

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

75.5

964

5122

S01ED51

ATC

timolol, combinations; ophthalmic

1.6

75.5

1652

10265

M79.7

ICD-10 Finland

Fibromyalgia

2.0

75.4

859

4392

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

3.3

75.4

286

872

Z00.0

ICD-10 Finland

General medical examination

1.4

75.3

4547

34694

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

75.3

1889

12138

C09AA05

ATC

ramipril; oral

1.3

75.0

5330

41705

R35

ICD-10 Finland

Polyuria

1.7

74.9

1551

9502

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.8

74.7

1070

5901

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

74.6

4528

34572

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

74.4

1774

11260

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

74.1

5737

45449

R01AD12

ATC

fluticasone furoate; nasal

1.3

74.0

7355

60321

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

74.0

1176

6693

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

73.8

1309

7688

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

73.6

1434

8642

PAW37

NOMESCO Finland

Biopsy of temporal artery

4.0

73.6

213

542

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

73.5

359

1267

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

73.2

3086

22116

D12

ICPC

Constipation

1.9

73.2

919

4856

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.3

73.1

570

2517

AN1

Coronary angiography

1.5

73.0

2219

14890

SPAT1153

SPAT

Removal of sutures

1.3

72.9

7057

57646

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

72.9

5522

43590

207

Kela drug reimbursment

Chronic arrhythmias

1.4

72.7

3405

24874

S04

ICPC

Lump/swelling localized

1.5

72.7

2648

18451

CEW99

NOMESCO Finland

Other operation on extraocular muscle

13.7

72.3

M01AH05

ATC

etoricoxib; oral

1.3

72.3

14909

133504

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

71.9

459

1854

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

71.8

2247

15169

183

Kela drug reimbursment

Lamotrigin and topiramate

3.4

71.8

255

746

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

71.7

2534

17544

J01EA01

ATC

trimethoprim; systemic

1.3

71.7

5950

47570

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

71.6

4600

35409

SPAT1240

SPAT

Therapeutic discussion

1.5

71.6

2385

16315

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

71.6

2297

15591

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

7.7

71.5

100

131

R03AC03

ATC

terbutaline; inhalant

1.4

71.2

3085

22215

L16

ICPC

Ankle symptom/complaint

1.5

70.4

2853

20285

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.1

70.3

661

3148

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

70.2

1554

9679

K91

ICPC

Cerebrovascular disease

2.9

70.2

339

1189

A06AD11

ATC

lactulose; oral

1.4

69.9

3099

22405

N05CF02

ATC

zolpidem; oral

1.4

69.8

3848

28893

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

69.7

2766

19589

J01FA09

ATC

clarithromycin; systemic

1.3

69.6

7107

58391

H81.3

ICD-10 Finland

Other peripheral vertigo

2.1

69.4

693

3378

C08DA01

ATC

verapamil; systemic

1.9

69.0

901

4822

H50.8

ICD-10 Finland

Other specified strabismus

8.4

68.9

106

W19

ICD-10 Finland

Unspecified fall

1.5

68.7

2272

15511

N07CA01

ATC

betahistine; oral

1.6

68.6

1581

9946

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

68.5

1113

6374

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

68.4

2124

14310

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

3.6

68.3

226

631

S01EC01

ATC

acetazolamide; systemic

2.3

68.2

501

2157

R83

ICPC

Respiratory infection other

1.3

68.1

5956

47910

N06AX26

ATC

vortioxetine; oral

1.6

68.0

1776

11511

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

67.8

996

5534

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.6

67.7

404

1580

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

67.7

753

3817

XKD00

NOMESCO Finland

Uroflowmetry

1.4

67.5

3114

22666

M54.8

ICD-10 Finland

Other dorsalgia

1.8

67.4

1098

6291

H92.0

ICD-10 Finland

Otalgia

1.6

67.3

1538

9655

I63.8

ICD-10 Finland

Other cerebral infarction

3.4

67.2

243

719

P03

ICPC

Feeling depressed

1.5

67.1

2398

16632

M48.0

ICD-10 Finland

Spinal stenosis

1.5

67.1

2687

19055

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

67.0

2124

14370

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

11.5

67.0

H34.8

ICD-10 Finland

Other retinal vascular occlusions

2.3

67.0

492

2118

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

66.9

4350

33504

D09

ICPC

Nausea

1.7

66.9

1171

6849

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

6.5

66.9

109

169

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.8

66.7

338

1217

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

66.4

789

4091

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

66.4

1681

10817

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

66.2

3292

24269

S80.0

ICD-10 Finland

Contusion of knee

1.6

66.2

1789

11684

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.5

65.8

420

1697

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

65.6

1733

11259

D19

ICPC

Teeth/gum symptom/complaint

1.3

65.4

7303

60589

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

65.2

4789

37550

H43.3

ICD-10 Finland

Other vitreous opacities

2.6

64.9

374

1438

SPAT1254

SPAT

Administration of medicine

1.4

64.9

3364

24971

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.5

64.9

432

1780

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

64.8

1716

11156

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

64.8

1624

10424

L14

ICPC

Leg/thigh symptom/complaint

1.5

64.7

1933

12910

CEC30

NOMESCO Finland

Resection of extraocular muscle

9.3

64.4

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.0

64.3

287

964

Z01.7

ICD-10 Finland

Laboratory examination

1.4

64.3

3889

29602

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

64.2

1093

6342

L04AA31

ATC

[U] teriflunomide

6.1

64.1

111

183

Z00.8

ICD-10 Finland

Other general examinations

1.5

64.1

1883

12530

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

3.8

64.0

193

506

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.9

63.8

818

4351

J20

ICD-10 Finland

Acute bronchitis

1.5

63.8

2401

16815

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

63.7

1402

8715

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.4

63.6

432

1796

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

63.4

770

4024

S22.3

ICD-10 Finland

Fracture of rib

1.6

63.2

1555

9936

WX872

NOMESCO Finland

Intensive care

1.8

63.1

1081

6284

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

62.8

629

3069

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

62.7

3039

22290

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.8

62.6

325

1185

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

62.6

1707

11170

A05

ICPC

Feeling ill

1.6

62.4

1487

9428

A08

ICPC

Swelling

1.7

62.3

1312

8064

SPAT1312

SPAT

General health counselling

1.3

62.3

7411

61890

N03AX18

ATC

lacosamide; systemic

3.3

62.3

231

695

M01AH01

ATC

celecoxib; oral

1.4

62.2

3888

29732

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

62.1

2279

15878

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

62.0

3544

26716

N04BC05

ATC

pramipexole; oral

1.6

62.0

1645

10694

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.6

62.0

351

1338

N02AA05

ATC

oxycodone; systemic

1.4

61.9

3937

30182

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

61.9

2365

16607

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

61.8

9170

78572

315

Kela drug reimbursment

Clopidogrel

3.2

61.8

242

753

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

61.7

6140

50129

SPAT1229

SPAT

Assessment of need for aid

1.6

61.7

1613

10452

XCW10

NOMESCO Finland

Assessment of vision

2.5

61.6

403

1647

A02BC04

ATC

rabeprazole; oral

1.5

61.2

1919

12945

N29

ICPC

Neurological sympt/complt other

2.3

61.2

472

2076

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

61.2

1295

7971

ZXD20

NOMESCO Finland

Day surgery

1.4

61.0

2714

19603

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

60.9

843

4597

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

60.8

2074

14237

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

60.8

2501

17808

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

60.6

983

5624

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

60.6

6001

48947

P29

ICPC

Psychological sympt/compl other

1.5

60.4

1751

11612

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

60.4

618

3040

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

60.3

873

4827

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

60.1

1071

6294

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.9

60.1

758

4011

R4130

NOMESCO Finland

Speech therapy

2.1

60.0

597

2906

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

59.8

5997

48977

I49.1

ICD-10 Finland

Atrial premature depolarization

1.8

59.7

857

4726

G45

ICD-10 Finland

Transient cerebral ischaemic attacks and related syndromes

3.8

59.7

184

490

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

59.6

6507

53707

G04CA02

ATC

tamsulosin; oral

1.3

59.6

4456

34972

EB1VA, ,

NOMESCO Finland

1.3

59.6

4115

31925

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

59.5

7023

58525

P76

ICPC

Depressive disorder

1.6

59.5

1532

9891

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

59.3

1307

8127

J01MA12

ATC

levofloxacin; systemic

1.3

59.2

3930

30311

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

59.0

6493

53640

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

58.9

710

3699

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

3.1

58.3

245

795

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

3.0

58.2

267

911

L86

ICPC

Back syndrome with radiating pain

1.6

58.1

1421

9060

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.7

58.0

1065

6312

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

57.8

566

2739

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

57.8

1005

5867

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

57.7

4980

39848

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

57.7

1381

8762

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

57.5

5993

49140

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.7

57.5

313

1170

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

57.4

1524

9908

G04BD12

ATC

mirabegron; oral

1.4

57.2

2641

19191

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

57.2

1304

8176

P74

ICPC

Anxiety disorder/anxiety state

1.7

57.1

1045

6186

EBA00

NOMESCO Finland

Extraction of tooth

1.2

57.1

8561

73262

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.2

57.0

496

2292

R03BA01

ATC

beclometasone; inhalant

1.4

56.9

3017

22442

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.7

56.9

298

1092

K85

ICPC

Elevated blood pressure

1.3

56.8

3703

28459

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

56.8

761

4106

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

6.0

56.6

165

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

56.5

1095

6584

J45

ICD-10 Finland

Asthma

1.4

56.3

2366

16897

S16

ICPC

Bruise/contusion

1.9

56.3

739

3962

K78

ICPC

Atrial fibrillation/flutter

1.5

56.2

1599

10555

D35.30

ICD-10 Finland

Craniopharyngoma

19.2

56.2

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

56.2

2852

21061

M54.1

ICD-10 Finland

Radiculopathy

1.8

56.0

880

4989

U05

ICPC

Urination problems other

1.7

55.8

1167

7158

H47.3

ICD-10 Finland

Other disorders of optic disc

4.8

55.8

125

261

WX704

NOMESCO Finland

Intubation

1.5

55.8

1831

12462

C10AA03

ATC

pravastatin; oral

1.6

55.7

1484

9651

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

55.6

1027

6094

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

55.6

5069

40834

M02AA07

ATC

piroxicam; topical

1.3

55.3

7746

65724

N05BA09

ATC

clobazam; oral

3.7

55.3

177

484

K59.0

ICD-10 Finland

Constipation

1.6

55.3

1272

7991

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

55.3

2094

14665

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

55.2

979

5745

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

55.1

901

5166

H35.6

ICD-10 Finland

Retinal haemorrhage

3.5

55.0

188

537

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

54.9

2925

21768

37300

ICD-8 Finland

Strabismus, Concomitans convergens

3.7

54.8

175

478

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

54.7

3028

22677

R5110, ,

SPAT

1.5

54.6

1932

13350

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

54.6

11581

102666

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

54.4

976

5745

N05BA12

ATC

alprazolam; oral

1.5

54.4

2048

14322

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.7

54.4

290

1073

S82

ICPC

Naevus/mole

1.4

54.4

3250

24634

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

54.2

1312

8343

M54

ICD-10 Finland

Dorsalgia

1.4

54.2

2793

20670

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

54.2

6615

55224

K07

ICPC

Swollen ankles/oedema

1.7

54.1

1060

6390

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

54.1

2969

22197

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

53.9

1316

8386

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

53.9

1535

10134

S01

ICPC

Pain/tenderness of skin

1.7

53.8

1073

6499

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.9

53.7

251

866

PD5AD

NOMESCO Finland

CT of aorta

2.1

53.7

536

2613

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

53.6

627

3235

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

53.6

1578

10494

J01DA09

ATC

[U] cefadroxil

1.3

53.5

5719

46972

SAA04

NOMESCO Finland

Special examination of mouth

1.6

53.5

1181

7342

N06AX12

ATC

bupropion; oral

1.5

53.5

1550

10270

J05AB11

ATC

valaciclovir; oral

1.4

53.5

3218

24412

3681A

ICD-9 Finland

Visual disturbances, Subjective visual disturbances

+∞

53.1

3682A

ICD-9 Finland

Visual disturbances, Diplopia

+∞

53.1

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

53.1

1377

8900

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

53.0

1273

8080

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

52.9

7617

64753

R1250

NOMESCO Finland

Evaluation of functional capability

2.0

52.7

559

2787

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

52.6

1624

10910

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

5.1

52.6

109

213

R52.1

ICD-10 Finland

Chronic intractable pain

3.0

52.4

235

792

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.7

52.3

281

1044

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

52.3

1470

9676

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.8

52.2

823

4670

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.8

52.1

266

962

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.1

52.1

490

2335

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

52.1

1217

7674

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.9

51.9

252

888

A23

ICPC

Risk factor NOS

1.4

51.9

2192

15662

R52.0

ICD-10 Finland

Acute pain

1.8

51.8

749

4139

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

51.7

1188

7458

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

51.5

1527

10166

L18

ICPC

Muscle pain

1.7

51.5

988

5923

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.4

51.4

360

1519

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.0

51.3

232

786

H33.5

ICD-10 Finland

Other retinal detachments

3.1

51.2

217

708

C09CA01

ATC

losartan; oral

1.3

51.2

5535

45484

C08CA13

ATC

lercanidipine; oral

1.4

51.2

3092

23462

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

51.1

671

3598

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

3.0

51.0

228

767

XCW12

NOMESCO Finland

Assessment of colour vision

13.4

51.0

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

50.9

381

1655

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

50.9

510

2490

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

50.8

691

3746

114

Kela drug reimbursment

Glaucoma

1.5

50.8

1734

11891

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

50.7

1297

8353

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.1

50.6

462

2177

G43

ICD-10 Finland

Migraine

1.6

50.5

1155

7242

R09

ICPC

Sinus symptom/complaint

1.5

50.5

1831

12708

R31

ICD-10 Finland

Unspecified haematuria

1.4

50.4

2061

14634

SPAT1050

SPAT

Extensive neurological examination

2.1

50.3

478

2288

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.3

50.3

366

1571

L20

ICPC

Joint symptom/complaint NOS

1.7

50.3

893

5243

G44.8

ICD-10 Finland

Other specified headache syndromes

2.4

50.2

356

1511

L03AB08

ATC

interferon beta-1b; parenteral

5.5

50.0

175

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

50.0

990

5985

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

49.9

1980

13979

R06.5

ICD-10 Finland

Mouth breathing

1.5

49.8

1864

13012

I20.09

ICD-10 Finland

Unstable angina

1.6

49.7

1096

6813

R25.2

ICD-10 Finland

Cramp and spasm

2.0

49.6

570

2923

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.9

49.5

240

845

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

49.5

480

2315

G44.0

ICD-10 Finland

Cluster headache syndrome

2.7

49.3

266

991

H13

ICPC

Plugged feeling ear

1.3

49.3

4288

34262

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

49.2

1234

7911

H25.8

ICD-10 Finland

Other senile cataract

1.4

49.2

2215

16002

M01AX17

ATC

nimesulide; oral

1.3

49.1

4935

40163

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.8

49.0

793

4533

F95

ICPC

Strabismus

7.2

49.0

100

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

48.9

2340

17083

U01

ICPC

Dysuria/painful urination

1.5

48.9

1834

12810

F13

ICPC

Eye sensation abnormal

1.9

48.8

666

3616

2AB04, ,

NOMESCO Finland

5.9

48.7

148

S01EE01

ATC

latanoprost; ophthalmic

1.6

48.7

1273

8240

L84

ICPC

Back syndrome without radiat pain

1.6

48.6

1052

6506

M54.3

ICD-10 Finland

Sciatica

1.6

48.6

1268

8203

R20.8

ICD-10 Finland

Other and unspecified disturbances of skin sensation

2.6

48.6

285

1107

N28

ICPC

Limited function/disability (N)

2.3

48.5

390

1746

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

48.4

727

4066

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

48.4

4138

32980

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

5.4

48.3

177

M05BA04

ATC

alendronic acid; oral

1.5

48.2

1775

12351

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

47.5

929

5597

R09.1

ICD-10 Finland

Pleurisy

2.2

47.4

422

1970

SFA00

NOMESCO Finland

Small restoration

1.3

47.2

3060

23450

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

47.1

1853

13057

H16.0

ICD-10 Finland

Corneal ulcer

1.6

47.1

1025

6349

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

47.0

2702

20326

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.1

47.0

457

2207

PA6AM

NOMESCO Finland

Simple MRI examination of neck vasculature with 3 Tesla magnet

6.8

46.9

108

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

46.8

697

3887

K04.08

ICD-10 Finland

Other specified pulpit

1.5

46.8

1650

11384

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

46.6

3311

25709

A27

ICPC

Fear of other disease NOS

1.6

46.6

1112

7045

L04AG12

ATC

ofatumumab; parenteral

8.6

46.4

A03FA02

ATC

cisapride; oral, rectal

1.5

46.3

1506

10220

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

46.3

920

5567

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.1

46.1

455

2210

ZX120

NOMESCO Finland

Intravenous

1.4

46.0

1926

13726

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

46.0

2449

18195

P99

ICPC

Psychological disorders other

1.8

45.9

664

3672

F45.0

ICD-10 Finland

Somatization disorder

3.8

45.8

137

358

G04CA01

ATC

alfuzosin; oral

1.4

45.8

2233

16349

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

45.7

3055

23508

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

9.2

45.6

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

45.4

1539

10534

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

45.3

1579

10865

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

45.3

550

2874

SGA01

NOMESCO Finland

Emergency treatment

1.3

45.2

3463

27171

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

45.1

743

4269

L57.0

ICD-10 Finland

Actinic keratosis

1.4

45.0

2223

16308

SPAT1325

SPAT

Vaccination

1.2

45.0

7419

63744

R06.4

ICD-10 Finland

Hyperventilation

2.3

44.9

358

1598

H43.9

ICD-10 Finland

Disorder of vitreous body, unspecified

2.7

44.7

240

892

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.4

44.5

307

1287

K04.0

ICD-10 Finland

Pulpitis

1.4

44.5

1881

13428

H01.0

ICD-10 Finland

Blepharitis

1.5

44.4

1507

10315

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

4.2

44.4

119

287

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

44.4

2317

17154

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.7

44.3

241

902

H50.6

ICD-10 Finland

Mechanical strabismus

12.7

44.3

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

44.2

1061

6730

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

2.9

44.2

204

700

H50.4

ICD-10 Finland

Other and unspecified heterotropia

9.5

44.1

N06AA10

ATC

nortriptyline; systemic

2.1

44.1

438

2133

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

44.0

8116

70488

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

44.0

668

3749

M01AC06

ATC

meloxicam; systemic, rectal

1.2

43.9

7784

67330

L04AX01

ATC

azathioprine; systemic

1.7

43.9

885

5375

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

43.9

1027

6476

UDC00

NOMESCO Finland

Ear microscopy

1.5

43.9

1580

10943

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.4

43.8

2091

15247

N64.4

ICD-10 Finland

Mastodynia

1.7

43.8

754

4388

K29

ICPC

Cardiovascular sympt/complt other

1.6

43.7

926

5696

S20.2

ICD-10 Finland

Contusion of thorax

1.6

43.7

1112

7152

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

43.7

1303

8683

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

43.6

1012

6368

N05AX12

ATC

aripiprazole; systemic

1.7

43.6

827

4943

102

Kela drug reimbursment

Diabetes insipidus

5.8

43.4

137

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

43.4

1768

12533

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

1.7

43.4

756

4414

K24

ICPC

Fear of heart disease

1.9

43.3

566

3030

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

3.2

43.3

170

531

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

43.3

873

5303

N07XX09

ATC

[U] dimethyl fumarate

5.7

43.2

141

J01CA08

ATC

pivmecillinam; oral

1.2

43.2

9372

82638

N05AH03

ATC

olanzapine; systemic

1.5

43.2

1278

8502

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.8

43.1

624

3451

S22

ICPC

Nail symptom/complaint

1.5

43.1

1485

10194

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.7

43.1

730

4229

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

4.8

43.0

200

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.5

42.9

1527

10550

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.8

42.8

625

3466

WZC30

NOMESCO Finland

Teaching

1.3

42.8

3546

28099

R01AD01

ATC

beclometasone; nasal

1.3

42.7

3126

24353

G51.0

ICD-10 Finland

Bell palsy

1.9

42.7

544

2890

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.8

42.6

703

4041

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

42.6

455

2274

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

42.6

533

2814

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

42.5

3557

28217

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.5

42.5

272

1102

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.5

42.5

148

429

S01EC04

ATC

brinzolamide; ophthalmic

1.7

42.4

791

4706

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

42.4

1109

7178

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

42.4

2283

16983

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

42.4

2658

20247

H51.2

ICD-10 Finland

Internuclear ophthalmoplegia

9.4

42.3

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

42.3

1107

7165

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

42.2

828

4993

R5599

NOMESCO Finland

Other rehabilitation service

1.9

42.1

583

3180

R04.2

ICD-10 Finland

Haemoptysis

1.8

42.1

675

3850

R07.2

ICD-10 Finland

Precordial pain

2.0

42.1

457

2299

R06AX22

ATC

ebastine; oral

1.3

42.0

3621

28835

H54.0

ICD-10 Finland

Blindness, binocular

68.6

42.0

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

42.0

9204

81172

ZXD35

NOMESCO Finland

Usual procedure

1.8

41.7

657

3726

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

41.7

1715

12175

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

41.7

540

2884

ZXY02

NOMESCO Finland

Neuropsychologist

3.5

41.6

143

411

G40.10

ICD-10 Finland

Simple partial seizures

3.0

41.6

181

601

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.8

41.5

211

763

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.4

41.4

293

1243

ZXC95

NOMESCO Finland

Use of surgical navigator

2.4

41.4

278

1152

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

2.8

41.3

202

715

H48.1*G35

ICD-10 Finland

Retrobulbar neuritis in multiple sclerosis

11.3

41.3

M01AH02

ATC

rofecoxib; oral

1.4

41.3

2521

19121

L60.0

ICD-10 Finland

Ingrowing nail

1.6

41.3

1050

6752

A07AA02

ATC

nystatin; oral

1.5

41.2

1192

7891

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

41.1

846

5165

K05

ICPC

Irregular heartbeat other

1.8

41.1

685

3951

F28

ICPC

Limited function/disability (F)

3.1

41.1

175

574

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.0

41.0

186

632

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

41.0

1097

7136

A91

ICPC

Abnormal result investigation NOS

1.5

40.9

1135

7445

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

40.8

706

4114

N06AX22

ATC

agomelatine; oral

1.9

40.8

496

2595

SDA03

NOMESCO Finland

Periodontal treatment

1.2

40.7

9361

82845

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

40.7

945

5945

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

40.7

16108

149526

R41.3

ICD-10 Finland

Other amnesia

1.8

40.6

612

3426

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

40.5

1202

7997

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

40.5

1576

11072

A13

ICPC

Concern/fear medical treatment

2.0

40.5

452

2295

L95

ICPC

Osteoporosis

1.7

40.5

843

5163

N76.0

ICD-10 Finland

Acute vaginitis

1.5

40.5

1373

9394

J46

ICD-10 Finland

Status asthmaticus

1.8

40.4

612

3431

N04BB01

ATC

amantadine; oral

2.2

40.4

328

1476

R03BB04

ATC

tiotropium bromide; inhalant

1.4

40.4

1958

14309

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

40.3

489

2556

XKC03

NOMESCO Finland

Water cystometry

1.8

40.3

619

3486

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

40.2

768

4599

H50.59

ICD-10 Finland

Heterophor UNS

7.2

40.1

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

40.1

3016

23569

R06.2

ICD-10 Finland

Wheezing

1.6

40.1

943

5952

A01AB09

ATC

miconazole; local oral

1.4

40.1

1759

12633

D03

ICPC

Heartburn

1.7

40.0

828

5062

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

40.0

526

2824

M75.8

ICD-10 Finland

Other shoulder lesions

1.7

39.9

819

4998

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

4.2

39.9

105

250

M02AA10

ATC

ketoprofen; topical

1.3

39.8

3295

26086

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

39.8

651

3735

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

4.7

39.7

194

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.5

39.6

1377

9465

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

39.6

1230

8264

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

3.0

39.6

173

576

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

39.5

2510

19148

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

39.3

4690

38819

UJH02

NOMESCO Finland

Anoscopy

1.6

39.3

826

5070

GD1AA, ,

SPAT

1.3

39.3

3426

27302

H02.3

ICD-10 Finland

Blepharochalasis

1.5

39.0

1342

9205

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

39.0

1169

7794

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

39.0

1216

8176

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

39.0

326

1485

H35.7

ICD-10 Finland

Separation of retinal layers

2.6

38.9

217

823

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.6

38.9

222

852

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

38.8

1673

11977

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

38.8

1132

7506

U71

ICPC

Cystitis/urinary infection other

1.4

38.8

1529

10770

SPAT1053

SPAT

Memory test

1.3

38.7

2761

21416

S01EA05

ATC

brimonidine; ophthalmic

1.9

38.6

488

2585

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.5

38.6

1134

7529

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

38.6

8656

76335

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

38.6

2674

20653

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.9

38.6

486

2573

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

38.5

1260

8556

PA2CG

NOMESCO Finland

Extensive MRI examination of vessels in the head with high intensity magnet

3.8

38.4

115

301

L09

ICPC

Arm symptom/complaint

1.5

38.4

1066

6991

L11

ICPC

Wrist symptom/complaint

1.4

38.4

2066

15357

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.2

38.2

333

1542

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

38.2

1496

10521

C05AA08

ATC

fluocortolone; rectal, topical

1.3

38.2

2729

21169

J01MA06

ATC

norfloxacin; oral

1.3

38.1

2594

19980

J01DA06

ATC

[U] cefuroxime

1.3

38.0

2889

22598

N30

ICD-10 Finland

Cystitis

1.4

38.0

1833

13378

X18

ICPC

Breast pain female

2.1

38.0

361

1730

R06AX13

ATC

loratadine; oral

1.3

37.9

3097

24462

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.0

37.9

406

2033

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.9

37.9

520

2830

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

37.8

651

3789

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

37.8

939

6005

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

37.8

1539

10905

D07AA02

ATC

hydrocortisone; topical

1.3

37.7

2944

23116

R44.1

ICD-10 Finland

Visual hallucinations

3.3

37.7

141

428

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

37.7

3753

30402

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

37.4

650

3793

WZC00, ,

SPAT

1.3

37.4

3370

26958

R20.0

ICD-10 Finland

Anaesthesia of skin

2.7

37.4

201

749

SPAT1104

SPAT

Monitoring of emergency patient

1.5

37.3

1287

8834

R30.0

ICD-10 Finland

Dysuria

1.6

37.3

926

5921

N06AX03

ATC

mianserin; oral

1.6

37.3

926

5922

K92.1

ICD-10 Finland

Melaena

1.5

37.2

1063

7014

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

3.0

37.2

169

575

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.6

37.2

919

5868

R33

ICD-10 Finland

Retention of urine

1.4

37.2

1463

10300

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.3

37.1

292

1298

I49.5

ICD-10 Finland

Sick sinus syndrome

1.7

37.1

729

4399

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

37.1

1996

14835

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

37.0

504

2736

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

37.0

1233

8404

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

37.0

676

4001

A46

ICD-10 Finland

Erysipelas

1.3

37.0

3022

23869

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

3.0

36.9

167

567

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

2.6

36.9

210

805

RS221, ,

NOMESCO Finland

2.2

36.9

298

1339

C03DA01

ATC

spironolactone; oral

1.3

36.8

2494

19193

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

36.8

1579

11292

S08

ICPC

Skin colour change

1.5

36.6

1150

7743

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

36.6

304

1382

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

36.6

7803

68416

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

36.5

5384

45547

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.6

36.5

870

5508

SBB10

NOMESCO Finland

Dental impressions

1.4

36.5

1461

10316

D07AC13

ATC

mometasone; topical

1.2

36.5

6180

53015

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.6

36.5

794

4917

F34.1

ICD-10 Finland

Dysthymia

1.7

36.5

740

4503

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.7

36.5

194

719

PA7DG

NOMESCO Finland

Very extended MRI examination of vessesl in brain and neck with high intensity magnet

6.6

36.4

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

36.4

2331

17790

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

3.4

36.4

132

393

H26.02

ICD-10 Finland

Presenil cataract

1.8

36.3

537

2992

EB1AA, ,

SPAT

1.5

36.2

1313

9100

I34.1

ICD-10 Finland

Mitral (valve) prolapse

1.8

36.1

519

2865

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

36.1

2776

21740

H57.0

ICD-10 Finland

Anomalies of pupillary function

3.1

36.1

148

475

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

36.0

598

3445

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

36.0

351

1698

M89.0

ICD-10 Finland

Algoneurodystrophy

2.7

36.0

196

735

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

36.0

1916

14211

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

36.0

659

3903

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.8

35.9

518

2864

N05CD07

ATC

temazepam; oral

1.3

35.9

2179

16499

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

35.7

472

2539

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

35.6

832

5245

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

35.6

817

5128

Z31.5

ICD-10 Finland

Genetic counselling

1.5

35.5

1084

7255

H35.8

ICD-10 Finland

Other specified retinal disorders

3.2

35.5

141

444

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

35.5

807

5053

F16

ICPC

Eyelid symptom/complaint

1.5

35.4

1113

7496

D07AD01

ATC

clobetasol; topical

1.3

35.4

3546

28725

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.7

35.3

686

4128

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

35.2

4656

38919

SPAT1043

SPAT

Audiometry

1.4

35.2

2016

15127

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

35.1

1150

7810

R29

ICPC

Respiratory symptom/complaint other

1.4

35.1

1445

10256

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

35.0

1236

8521

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

35.0

805

5055

F04

ICPC

Visual floaters/spots

3.3

35.0

133

408

C08CA05

ATC

nifedipine; systemic

1.5

34.9

1144

7769

Angiography of the heart and coronary arteries

1.5

34.9

1030

6845

N06BA04

ATC

methylphenidate; oral

1.7

34.9

696

4217

M05BX04

ATC

denosumab; parenteral

1.5

34.9

1266

8776

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.6

34.8

885

5689

UJD02

NOMESCO Finland

Gastroscopy

1.6

34.8

924

5999

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.0

34.8

377

1897

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3.6

34.8

114

318

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

34.7

620

3646

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

1.9

34.7

425

2230

R06AE09

ATC

levocetirizine; oral

1.3

34.5

2952

23442

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.6

34.5

202

786

K03.80

ICD-10 Finland

Irradiated enamel

1.5

34.4

1148

7827

SPAT1283

SPAT

Restricted health certificate

1.3

34.4

3557

28917

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.5

34.3

1045

6992

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.6

34.2

198

766

G36.9

ICD-10 Finland

Acute disseminated demyelination, unspecified

5.9

34.2

104

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

3.2

34.2

133

414

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

34.0

1219

8427

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

34.0

1144

7811

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

34.0

1715

12607

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.2

34.0

296

1372

N05BE01

ATC

buspirone; oral

1.8

33.9

561

3229

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.3

33.9

269

1200

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.4

33.8

1317

9251

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

33.6

1175

8083

H81.0

ICD-10 Finland

Ménière disease

1.8

33.6

476

2616

N06

ICPC

Sensation disturbance other

2.3

33.6

243

1042

K02

ICPC

Pressure/tightness of heart

1.8

33.6

470

2574

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

33.5

1366

9675

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

33.5

2465

19181

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

33.4

1276

8930

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

33.4

737

4581

F61.0

ICD-10 Finland

Mixed personality disorders

2.1

33.4

334

1633

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

33.3

750

4684

UDM02

NOMESCO Finland

Sinoscopy

1.9

33.3

441

2373

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

33.3

1852

13830

N06AX05

ATC

trazodone; oral

1.8

33.3

495

2763

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

33.2

793

5024

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

33.2

1333

9416

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

33.2

1634

11963

N02CC04

ATC

rizatriptan; oral

1.5

33.1

1091

7417

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

33.1

749

4684

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

33.1

1428

10219

XCD20

NOMESCO Finland

Photoangiography of eye

2.1

33.1

307

1459

B02.9

ICD-10 Finland

Zoster without complication

1.4

33.0

1395

9946

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

33.0

1023

6869

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

33.0

2446

19051

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

32.9

1893

14210

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

32.9

1557

11324

S70.0

ICD-10 Finland

Contusion of hip

1.6

32.9

780

4935

S01ED01

ATC

timolol; ophthalmic

1.7

32.8

641

3863

R1260

NOMESCO Finland

Evaluation of communicative skills

2.1

32.8

310

1484

R01AD05

ATC

budesonide; nasal

1.4

32.7

1459

10500

D10

ICPC

Vomiting

1.4

32.7

1252

8764

G04CB01

ATC

finasteride; oral

1.4

32.7

1842

13778

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.5

32.7

210

854

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

32.6

2130

16292

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

32.6

1025

6902

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

32.6

1001

6709

S09.9

ICD-10 Finland

Unspecified injury of head

2.1

32.6

329

1614

H81

ICPC

Excessive ear wax

1.3

32.6

3654

29969

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

32.6

632

3802

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.0

32.5

375

1928

H06.2

ICD-10 Finland

Dysthyroid exophthalmos

5.5

32.4

113

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

32.4

2264

17488

L04AA06

ATC

mycophenolic acid; systemic

1.9

32.3

389

2030

H81.4

ICD-10 Finland

Vertigo of central origin

2.7

32.3

173

644

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.9

32.2

440

2392

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.7

32.2

598

3555

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

32.2

1257

8834

J01MA14

ATC

moxifloxacin; systemic

1.4

32.1

1729

12842

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

32.1

1026

6934

M01AB55

ATC

diclofenac, combinations; oral

1.4

32.1

1256

8831

J01FA01

ATC

erythromycin; systemic

1.3

32.1

2760

21921

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.8

32.0

484

2714

F80.1

ICD-10 Finland

Expressive language disorder

2.5

32.0

203

821

R15

ICD-10 Finland

Faecal incontinence

1.7

32.0

583

3449

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

32.0

1006

6776

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

32.0

2096

16040

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

31.9

2341

18203

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.0

31.9

360

1838

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

31.8

2725

21628

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

31.8

776

4942

L19

ICPC

Muscle symptom/complaint NOS

1.7

31.8

617

3712

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.5

31.8

863

5632

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

31.7

1430

10312

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

2.8

31.7

161

583

N06AG02

ATC

moclobemide; oral

1.6

31.6

813

5242

K03.00

ICD-10 Finland

Approximal wear

1.4

31.5

1593

11709

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

31.5

1671

12380

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

31.5

999

6741

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.6

31.5

777

4962

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

31.4

939

6256

F27

ICPC

Fear of eye disease

2.4

31.4

222

943

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

31.4

859

5615

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

3.2

31.4

125

395

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

1.7

31.4

574

3400

R03AC13

ATC

formoterol; inhalant

1.5

31.3

952

6366

H82

ICPC

Vertiginous syndrome

1.9

31.3

370

1919

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

31.3

909

6022

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

31.2

586

3495

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

31.2

1133

7854

H26.2

ICD-10 Finland

Complicated cataract

2.2

31.1

251

1129

GEC24

NOMESCO Finland

Thoracoscopic thymectomy

6.4

31.1

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.2

31.1

265

1219

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

31.0

509

2924

H35.4

ICD-10 Finland

Peripheral retinal degeneration

2.7

31.0

171

646

N02CD06

ATC

rimegepant; oral

2.9

31.0

147

513

WX702

NOMESCO Finland

Supraglottic ventilation device

1.5

31.0

1139

7912

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.4

31.0

1189

8329

SPAT1211

SPAT

Application of soft bandage

1.4

30.9

1777

13331

B80

ICPC

Iron deficiency anaemia

1.7

30.8

550

3236

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

30.8

1303

9291

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

30.8

755

4814

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

30.8

6460

56373

A02BA04

ATC

nizatidine; systemic

1.4

30.6

1370

9866

Z50.1

ICD-10 Finland

Other physical therapy

1.5

30.6

1021

6960

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

30.6

1500

10971

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

30.5

972

6564

N19

ICPC

Speech disorder

2.1

30.5

282

1339

P25

ICPC

Phase of life problem adult

1.5

30.5

890

5901

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.1

30.4

282

1340

SPAT1058

SPAT

PEF monitoring instruction

1.4

30.4

1606

11892

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

30.4

2535

20048

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

30.2

1355

9762

R49.01

ICD-10 Finland

Functional dysphonia

1.7

30.1

578

3467

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

30.1

1327

9531

R01AD11

ATC

triamcinolone; nasal

1.4

30.1

1678

12529

J01DC02

ATC

cefuroxime; systemic

1.5

30.1

1052

7238

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.8

30.1

467

2641

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.3

30.0

1895

14416

J45.8

ICD-10 Finland

Mixed asthma

1.7

30.0

593

3586

L50.0

ICD-10 Finland

Allergic urticaria

1.7

30.0

535

3148

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

29.9

6453

56418

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.9

29.9

409

2226

WX882

NOMESCO Finland

High dependency care

1.7

29.9

559

3332

DFF59

NOMESCO Finland

Other assessment of balance

2.4

29.8

211

897

S10

ICPC

Boil/carbuncle

1.4

29.8

1199

8471

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

2.8

29.8

148

530

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

29.8

22601

218236

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

29.8

1952

14934

N06AB05

ATC

paroxetine; oral

1.4

29.7

1126

7869

L04AA52

ATC

[U] ofatumumab; parenteral

9.5

29.7

SPAT1255

SPAT

Intravenous administration of medicine

1.4

29.6

1286

9210

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

29.6

2063

15920

C01BC04

ATC

flecainide; systemic

1.6

29.6

661

4123

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

29.5

814

5330

S01EE05

ATC

tafluprost; ophthalmic

1.6

29.5

674

4225

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.7

29.5

529

3116

H05.2

ICD-10 Finland

Exophthalmic conditions

4.1

29.5

191

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

10.7

29.5

D68.8

ICD-10 Finland

Other specified coagulation defects

2.2

29.5

237

1064

CAC10

NOMESCO Finland

Reconstruction of orbital wall using bone graft or plate

4.6

29.5

154

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

29.5

1703

12784

Y94.8

ICD-10 Finland

Other leisure activity accident

1.7

29.4

546

3248

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.7

29.4

536

3173

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

29.4

3779

31434

D21

ICPC

Swallowing problem

2.0

29.4

308

1533

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

5.1

29.3

120

G83.4

ICD-10 Finland

Cauda equina syndrome

3.2

29.3

113

350

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.5

29.3

181

724

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.6

29.1

652

4068

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.3

29.1

2038

15738

K04.09

ICD-10 Finland

Pulpit UNS

1.5

29.0

895

6003

N88

ICPC

Epilepsy

2.8

29.0

149

543

XA402

NOMESCO Finland

ENMG

1.8

29.0

469

2684

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.9

29.0

373

1991

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

29.0

4973

42572

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.1

29.0

117

373

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

3.2

29.0

116

368

K83

ICPC

Heart valve disease NOS

2.3

28.9

207

885

R04

ICPC

Breathing problem other

1.5

28.9

784

5117

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

28.9

2147

16716

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

28.9

1852

14123

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.6

28.8

165

636

N03

ICPC

Pain face

2.3

28.8

209

899

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.6

28.8

742

4788

G40

ICD-10 Finland

Epilepsy

2.4

28.7

194

808

D16

ICPC

Rectal bleeding

1.7

28.7

515

3035

H15.1

ICD-10 Finland

Episcleritis

2.0

28.7

306

1533

H26.9

ICD-10 Finland

Cataract, unspecified

2.0

28.6

332

1712

I63

ICD-10 Finland

Cerebral infarction

2.6

28.6

166

644

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

2.6

28.6

164

633

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.3

28.5

1685

12692

C10AC01

ATC

colestyramine; oral

1.7

28.5

555

3343

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.4

28.5

1171

8306

D82

ICPC

Teeth/gum disease

1.2

28.5

8444

75719

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.1

28.4

264

1256

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

28.4

1314

9514

4AA23, ,

NOMESCO Finland

7.3

28.3

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

3.0

28.3

121

399

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.6

28.3

683

4341

E000001, ,

ATC

1.2

28.2

4101

34530

T74.1

ICD-10 Finland

Physical abuse

1.9

28.2

359

1910

N03AB02

ATC

phenytoin; systemic

2.3

28.2

206

889

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.6

28.1

162

626

A10AB05

ATC

insulin aspart; parenteral

1.4

28.1

1457

10751

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

7.9

28.1

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

28.0

666

4216

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

8.8

28.0

XQ802

NOMESCO Finland

Epicutan test

1.5

28.0

774

5073

H66.9

ICD-10 Finland

Otitis media, unspecified

1.4

28.0

1370

10016

280

Kela drug reimbursment

Clopidogrel

2.2

27.9

247

1154

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.5

27.9

176

711

M77.4

ICD-10 Finland

Metatarsalgia

1.4

27.9

1222

8767

D07AB08

ATC

desonide; topical

1.3

27.8

2167

16979

A85

ICPC

Adverse effect medical agent

2.1

27.7

249

1170

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

27.7

1311

9530

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

27.7

809

5366

H50.50

ICD-10 Finland

Alternating hyperphoria

5.5

27.6

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

27.6

1531

11419

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

2.7

27.6

143

524

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

27.6

426

2406

J34.2

ICD-10 Finland

Deviated nasal septum

1.5

27.6

952

6535

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

27.5

4818

41292

K84

ICPC

Heart disease other

1.7

27.5

536

3230

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

2.3

27.5

209

918

N06AA12

ATC

doxepin; systemic

1.5

27.4

927

6335

C10AA04

ATC

fluvastatin; oral

1.4

27.4

1561

11689

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.5

27.4

755

4943

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

27.4

9917

90200

J01

ICD-10 Finland

Acute sinusitis

1.4

27.4

1125

7978

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

2.1

27.3

252

1196

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

27.3

1045

7315

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

4.2

27.3

168

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

27.3

3570

29725

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.7

27.3

531

3198

F03

ICPC

Eye discharge

1.4

27.3

1429

10563

K11.2

ICD-10 Finland

Sialoadenitis

1.6

27.3

662

4213

D01AE16

ATC

amorolfine; topical

1.3

27.2

2225

17539

SPAT1234

SPAT

Support of social functional capacity

1.5

27.1

960

6620

N27

ICPC

Fear of neurological disease other

1.9

27.1

349

1863

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

27.1

906

6178

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.0

27.1

287

1434

L03AB13

ATC

peginterferon beta-1a; parenteral

6.8

27.1

S01EE03

ATC

bimatoprost; ophthalmic

1.8

27.1

416

2347

EMAK, ,

NOMESCO Finland

1.6

27.0

688

4426

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

27.0

859

5801

U04

ICPC

Incontinence urine

1.4

26.9

1154

8246

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.7

26.9

489

2892

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.0

26.9

302

1540

N02CD03

ATC

fremanezumab; systemic

2.3

26.9

197

851

R08

ICPC

Nose symptom/complaint other

1.6

26.9

714

4637

H53.6

ICD-10 Finland

Night blindness

62.1

26.9

E000006, ,

ATC

1.4

26.9

1298

9467

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

26.9

1303

9510

H33.2

ICD-10 Finland

Serous retinal detachment

4.2

26.9

166

K01

ICPC

Heart pain

2.1

26.9

267

1304

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

26.8

5270

45631

A06AC51

ATC

ispaghula, combinations; oral

1.5

26.8

930

6389

H3603, E103,

ICD-10 Finland

2.4

26.8

186

785

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

3.2

26.8

104

324

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

26.8

4366

37160

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

3.1

26.7

111

360

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

26.7

673

4320

F41.00

ICD-10 Finland

Moderate panic disorder

2.0

26.7

307

1579

N80

ICPC

Head injury other

1.8

26.7

424

2415

L50.9

ICD-10 Finland

Urticaria, unspecified

1.5

26.6

776

5146

R06

ICPC

Nose bleed/epistaxis

1.7

26.5

483

2859

A92

ICPC

Allergy/allergic reaction NOS

1.6

26.5

645

4108

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

1.9

26.5

309

1598

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.7

26.4

454

2644

N99

ICPC

Neurological disease other

2.1

26.4

257

1245

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.7

26.4

474

2794

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.9

26.4

327

1725

R10.0

ICD-10 Finland

Acute abdomen

1.6

26.4

647

4128

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.4

26.3

1018

7141

A03CA02

ATC

clidinium and psycholeptics; oral

1.4

26.2

1046

7378

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

26.2

654

4188

N05AX08

ATC

risperidone; systemic

1.3

26.2

1587

11994

SPAT1101

SPAT

Orthostatic test

1.5

26.1

772

5135

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

3.1

26.1

108

350

I67.0

ICD-10 Finland

Dissection of cerebral arteries, nonruptured

4.6

26.0

133

B02AA02

ATC

tranexamic acid; systemic

1.2

26.0

2916

23869

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.5

26.0

713

4665

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

5.3

26.0

N02CC06

ATC

eletriptan; oral

1.6

25.9

657

4223

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

3.0

25.9

113

377

J02AC02

ATC

itraconazole; systemic

1.2

25.9

3498

29210

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.7

25.9

134

491

WX720

NOMESCO Finland

Own respiration

1.5

25.9

952

6616

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

25.9

4120

34976

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

1.6

25.9

631

4021

H40.11

ICD-10 Finland

Low pressure glaucoma

1.8

25.8

408

2322

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

2.6

25.8

143

543

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.8

25.8

387

2169

SPAT1252

SPAT

Overall medication plan or its review

1.4

25.7

1253

9151

PA7CG

NOMESCO Finland

Extended MRI examination of vessesl in brain and neck with high intensity magnet

5.2

25.7

100

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.3

25.7

1897

14749

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

25.7

1903

14803

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

25.7

953

6634

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

25.6

323

1714

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

25.6

2194

17394

L04AX03

ATC

methotrexate; systemic

1.3

25.6

1915

14915

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

25.6

449

2632

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

3.4

25.5

264

A10AE04

ATC

insulin glargine; parenteral

1.3

25.5

1803

13934

S02

ICPC

Pruritus

1.5

25.5

756

5032

X15

ICPC

Vaginal symptom/complaint other

1.5

25.4

809

5465

PA2AG

NOMESCO Finland

Restrected MRI examination of vessels in the head with high intensity magnet

4.0

25.3

178

DHB50

NOMESCO Finland

Turbinoplasty

1.7

25.3

472

2813

M01AX01

ATC

nabumetone; oral

1.5

25.3

770

5153

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.6

25.2

576

3613

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.5

25.2

792

5334

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.5

25.2

758

5059

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

25.2

828

5628

XCH05

NOMESCO Finland

Eye pressure longterm registration

2.3

25.2

194

857

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

25.2

1009

7124

S12

ICPC

Insect bite/sting

1.3

25.2

1734

13352

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.5

25.2

902

6237

A06AX04

ATC

linaclotide; oral

3.1

25.1

102

327

R19.4

ICD-10 Finland

Change in bowel habit

1.6

25.1

592

3744

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

25.0

615

3925

-60

ICPC

Result test/procedure

1.4

25.0

1096

7863

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

2.0

25.0

273

1380

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

6.7

25.0

R49.08

ICD-10 Finland

Other specified dysphonia

1.7

25.0

425

2470

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.6

25.0

536

3312

L04AE01

ATC

fingolimod; oral

7.4

25.0

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

1.8

24.9

400

2287

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

24.9

635

4089

K99

ICPC

Cardiovascular disease other

1.7

24.9

486

2932

AA9CW, ,

NOMESCO Finland

4.5

24.9

130

S97

ICPC

Chronic ulcer skin

1.4

24.9

1205

8794

F32

ICD-10 Finland

Depressive episode

1.4

24.9

1074

7686

FN1AD

NOMESCO Finland

CT of coronary arteries

1.8

24.8

357

1975

SPAT1009

SPAT

Measurement of intraocular pressure

2.0

24.8

260

1295

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.6

24.8

579

3651

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

2.5

24.8

154

618

X57

ICD-10 Finland

Unspecified privation

1.7

24.8

432

2527

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.3

24.8

186

813

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.5

24.7

725

4813

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.0

24.7

276

1406

R2110

NOMESCO Finland

Giving the first information

1.4

24.7

1287

9503

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

24.7

4399

37718

K03.66

ICD-10 Finland

Tooth plaque

1.3

24.7

1603

12239

U29

ICPC

Urinary symptom/complaint other

1.6

24.7

610

3899

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

2.6

24.7

144

561

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

24.7

2540

20586

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

1.9

24.6

302

1588

M01AX05

ATC

glucosamine; oral

1.2

24.6

3754

31717

S06

ICPC

Rash localized

1.4

24.6

1141

8264

K12.00

ICD-10 Finland

Recurrent oral aphthae

1.9

24.6

292

1519

VALMI, ,

NOMESCO Finland

1.2

24.6

5139

44686

OAB93, ,

SPAT

1.4

24.6

1276

9416

P01BA02

ATC

hydroxychloroquine; oral

1.3

24.6

1595

12178

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.5

24.5

884

6119

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.9

24.5

311

1654

G03DB01

ATC

dydrogesterone; oral

1.3

24.5

2379

19147

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

3.5

24.4

238

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

2.0

24.4

273

1392

I20.00

ICD-10 Finland

Unstable angina

1.7

24.4

481

2910

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.5

24.4

732

4886

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

24.3

539

3357

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

2.3

24.3

187

826

R41.0

ICD-10 Finland

Disorientation, unspecified

1.6

24.3

549

3436

E66.8

ICD-10 Finland

Other obesity

1.4

24.3

1070

7685

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

24.3

777

5255

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.5

24.3

889

6174

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

4.0

24.2

175

104

Kela drug reimbursment

Thyroid insufficiency

1.4

24.2

1357

10138

-50

ICPC

Medication/prescr/renewal

1.5

24.1

736

4928

SPAT1262

SPAT

Handing over of treatment supplies

1.2

24.1

3377

28289

J01CF05

ATC

flucloxacillin; systemic

1.4

24.1

1389

10419

C07AB12

ATC

nebivolol; oral

1.6

24.1

539

3365

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.0

24.1

247

1221

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.4

24.1

1283

9507

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.4

24.1

966

6822

SGC10

NOMESCO Finland

Pulp capping

1.3

24.0

1642

12631

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.2

24.0

2696

22065

T89

ICPC

Diabetes insulin dependent

1.5

24.0

722

4822

G04BD08

ATC

solifenacin; oral

1.4

24.0

1227

9036

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

4.5

23.9

126

R25.3

ICD-10 Finland

Fasciculation

2.9

23.9

108

368

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.5

23.9

694

4600

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.5

23.8

150

606

-1, ,

ICPC

1.5

23.8

688

4553

G91.1

ICD-10 Finland

Obstructive hydrocephalus

3.2

23.8

291

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

3.4

23.8

242

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.7

23.8

485

2960

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.3

23.7

2105

16755

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

3.2

23.7

302

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

23.7

860

5962

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.8

23.7

336

1852

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

2.8

23.6

120

436

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.7

23.6

441

2630

IHZ05, ,

SPAT

1.4

23.6

892

6231

NH1AD

NOMESCO Finland

Ankle and foot CT

1.7

23.6

451

2706

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.1

23.6

235

1150

R20.1

ICD-10 Finland

Hypoaesthesia of skin

2.6

23.6

137

533

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

23.6

889

6208

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.3

23.6

175

762

K86

ICPC

Hypertension uncomplicated

1.2

23.5

2689

22047

H03BB01

ATC

carbimazole; oral

1.5

23.5

779

5305

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

5.1

23.5

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

23.4

1064

7681

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.0

23.4

247

1234

S06.3

ICD-10 Finland

Focal brain injury

2.1

23.4

230

1120

H60.8

ICD-10 Finland

Other otitis externa

1.6

23.4

611

3957

A10AC01

ATC

insulin (human); parenteral

1.4

23.3

1324

9908

L04AA40

ATC

cladribine; oral

6.8

23.3

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

23.3

1553

11903

L84

ICD-10 Finland

Corns and callosities

1.5

23.3

658

4336

S50.0

ICD-10 Finland

Contusion of elbow

1.6

23.3

602

3890

S15

ICPC

Foreign body in skin

1.4

23.2

1282

9552

U13

ICPC

Bladder symptom/complaint other

1.6

23.2

560

3560

ACC51

NOMESCO Finland

Release of median nerve

1.3

23.2

1444

10958

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.5

23.1

146

591

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.6

23.1

569

3635

M15

ICD-10 Finland

Polyarthrosis

1.4

23.1

968

6891

N05

ICPC

Tingling fingers/feet/toes

2.0

23.1

252

1275

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

23.0

589

3796

RS222, ,

NOMESCO Finland

2.1

23.0

221

1067

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.6

23.0

470

2870

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.9

22.9

307

1662

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.3

22.9

166

715

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

22.9

581

3737

3684A

ICD-9 Finland

Visual disturbances, Visual field defects[HOMONYYMIT NÄKÖKENTTÄPUUTOKSET]

+∞

22.9

R1250, ,

SPAT

1.5

22.8

633

4155

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

22.8

1252

9323

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

22.8

1005

7219

N02CC07

ATC

frovatriptan; oral

1.5

22.7

712

4794

IBA03

NOMESCO Finland

Psychotherapy evaluation

2.2

22.7

187

850

N02CD01

ATC

erenumab; parenteral

2.3

22.7

170

743

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

6.2

22.7

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

4.9

22.7

100

N06BA07

ATC

modafinil; oral

3.2

22.6

285

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.0

22.6

257

1318

D25

ICPC

Abdominal distension

1.7

22.6

403

2373

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

22.6

781

5362

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

1.6

22.6

564

3614

CKC10

NOMESCO Finland

Local photocoagulation of retina

1.9

22.6

290

1549

CD994

NOMESCO Finland

Scan or assessment of eye not included in other categories

9.3

22.6

H35.9

ICD-10 Finland

Retinal disorder, unspecified

2.7

22.6

121

452

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

22.6

2637

21664

A60

ICPC

General and Unspecified, Result test/procedure

1.5

22.6

814

5636

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.4

22.6

927

6575

RD210, ,

NOMESCO Finland

1.8

22.6

337

1887

R19.5

ICD-10 Finland

Other faecal abnormalities

1.8

22.6

346

1953

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

1.8

22.5

341

1919

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13918

106748

1.63

320.14

2.4

2.1

97.24

96.46

pmol/l

1.12

7451

56784

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21636

186056

1.82

320.03

5.5

4.5

14.77

14.76

pmol/l

0.43

20166

171311

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3107

15273

2.17

315.70

1.4

1.3

40.82

52.75

au/ml

2.19

133

968

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

24308

217640

2.16

313.37

6.9

5.5

1.84

1.90

mu/l

11.79

22958

202438

(3024561) Albumin [Mass/volume] in Serum or Plasma

14420

108973

1.69

307.65

5.5

5.1

36.08

35.71

g/l

13.76

13613

102176

(3037467) Urinalysis macro (dipstick) panel - Urine

19837

165233

1.75

307.65

5.9

4.6

3.01

4.31

0.27

246

(3002030) Lymphocytes/Leukocytes in Blood

15110

117750

1.64

307.65

7.8

6.6

27.83

27.92

0.52

14444

111736

(3019198) Lymphocytes [#/volume] in Blood

16390

127515

1.72

307.65

7.7

6.4

1.88

1.92

e9/l

3.10

14497

112190

(3032080) INR in Blood by Coagulation assay

15376

108786

1.96

307.65

17.5

14.4

1.26

1.25

inr

2.52

13107

90692

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

776

1536

5.17

307.65

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

9170

61072

1.76

307.65

4.8

4.2

90.34

89.95

0.79

8986

59725

(3013826) Glucose [Moles/volume] in Serum or Plasma

19059

140383

2.21

307.65

6.3

5.0

6.50

6.67

mmol/l

30.20

18354

132510

(42870588) Differential panel, method unspecified - Blood

11546

83464

1.67

307.65

7.4

6.5

5.13

3.99

—

(3022096) Basophils/Leukocytes in Blood

14861

114592

1.66

307.65

7.9

6.7

0.68

0.57

14062

107434

(3031040) Bacteria [#/volume] in Urine by Automated count

19279

159319

1.73

307.65

6.2

4.7

1619.00

1818.91

e6/l

0.12

210

2196

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7589

35386

2.59

307.65

2.4

2.2

29.31

29.63

4.64

7405

34397

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

8033

53185

1.73

307.65

2.2

1.8

1.09

1.26

mg/l

4.51

6148

41317

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

16433

121784

1.89

307.65

8.5

7.2

1.21

mmol/l

1.44

14545

105102

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

848

1695

5.13

307.65

1.2

43.44

41.70

mg/l

0.21

737

1424

(3019069) Monocytes/Leukocytes in Blood

14913

114906

1.66

307.65

7.9

6.7

8.81

8.79

0.31

14125

107871

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12680

88894

1.80

307.65

4.8

3.7

66.12

63.51

ng/l

0.04

8801

60581

(3018010) Neutrophils/Leukocytes in Blood

14944

115519

1.66

307.65

7.7

6.4

57.19

57.23

0.17

14371

110426

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13119

72090

2.59

307.65

2.6

2.2

160.59

208.07

u/l

3.71

12656

68002

(3013650) Neutrophils [#/volume] in Blood by Automated count

17514

139280

1.73

307.65

10.7

9.7

4.06

4.13

e9/l

3.13

15295

120698

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16215

126747

1.70

307.65

6.9

6.5

10.92

11.47

umol/l

8.15

15477

120630

(3001604) Monocytes [#/volume] in Blood

16181

124587

1.74

307.65

7.7

6.4

0.58

e9/l

2.40

14035

107080

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7454

45459

1.88

307.65

4.9

3.8

371.27

438.04

ng/l

0.54

5558

35022

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1624

5211

3.25

307.65

1.3

3.66

3.73

mmol/l

1.78

1529

4947

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3344

16539

2.17

307.65

2.6

2.4

21.43

21.15

au/ml

0.06

293

1831

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

21633

182316

1.93

307.65

9.6

8.3

77.49

79.19

u/l

6.42

20733

173191

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

818

1637

5.12

307.65

1.1

269.45

258.17

mg/l

0.28

739

1458

(3013115) Eosinophils [#/volume] in Blood

16592

128644

1.75

307.65

7.9

6.6

0.19

e9/l

1.78

14587

112307

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1577

5234

3.14

307.65

1.5

1227.26

2442.97

e6/l

0.69

1251

4131

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

901

1047

8.87

307.65

1.1

3.89

7.82

nmol/l

1.10

186

189

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

21517

176487

2.07

307.65

5.5

4.4

11.40

12.06

mm/h

10.33

20466

165219

(3006315) Basophils [#/volume] in Blood

16227

124916

1.75

307.65

7.7

6.4

0.04

e9/l

0.78

14061

107330

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1805

5866

3.23

307.65

1.4

516.88

523.73

mg/l

0.14

1730

5626

(3006504) Eosinophils/Leukocytes in Blood

14881

114597

1.66

307.65

7.8

6.6

2.81

2.84

0.65

14094

107520

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1561

5165

3.15

307.65

1.4

1.5

29.28

35.99

e6/l

0.24

1176

3819

(3018418) pH of Serum or Plasma

10400

73163

1.69

307.65

4.7

4.3

7.40

0.01

7657

52097

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

15027

108901

1.86

307.65

7.7

6.6

1.21

mmol/l

1.00

14092

100837

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

886

2262

4.02

304.67

1.1

34.77

73.65

au/ml

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

644

1278

5.14

304.03

1.2

1.3

0.65

0.67

ratio

0.18

385

732

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

25402

232272

2.55

300.35

22.4

15.8

21.47

24.23

mg/l

39.56

21891

191189

(3019550) Sodium [Moles/volume] in Serum or Plasma

25555

234411

2.65

298.52

25.8

18.5

139.67

139.65

mmol/l

0.64

25305

229762

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9828

70032

1.63

298.19

3.6

3.2

1215.95

1368.60

ng/l

3.23

8488

60214

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

600

1144

5.34

296.33

1.1

1.12

1.11

u/l

0.10

249

466

(3023103) Potassium [Moles/volume] in Serum or Plasma

25564

234820

2.63

292.41

26.1

18.7

3.96

mmol/l

2.31

25280

229796

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

11549

87119

1.57

266.66

4.3

3.4

1.70

2.19

e6/l

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10458

77674

1.56

255.04

3.2

2.7

58.09

63.60

u/l

2.36

9732

71998

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14060

111548

1.54

254.17

2.8

2.5

76.94

885.36

nmol/l

0.50

12861

101474

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4031

23313

1.86

254.12

2.5

2.3

369.45

381.66

nmol/l

2.79

3739

21674

(3021960) Folate [Moles/volume] in Serum or Plasma

9513

69407

1.57

249.36

1.8

1.7

20.22

20.24

nmol/l

0.04

8240

59149

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

276

294

9.47

232.69

1.2

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6122

40751

1.65

231.91

3.7

3.5

0.82

mmol/l

3.54

5759

38293

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8938

65164

1.56

230.39

2.6

2.4

2.65

2.81

mg/l

9.86

7813

56366

(3002582) Erythrocytes [#/volume] in Urine

10516

79629

1.52

226.84

4.3

3.4

57.00

86.73

e6/l

2.24

8290

60354

(3015377) Calcium [Moles/volume] in Serum or Plasma

10977

84143

1.51

221.95

3.4

3.5

2.35

2.36

mmol/l

5.95

9963

76622

(3018095) Leukocytes [#/volume] in Urine

11765

91551

1.50

220.90

5.1

4.0

75.25

99.81

e6/l

2.30

8636

63646

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6027

40387

1.63

220.64

2.1

1.9

—

(3030467) Casts [#/volume] in Urine by Automated count

9305

68970

1.53

219.83

4.1

3.3

0.32

0.41

e6/l

4.95

7061

50210

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

18652

159739

1.54

219.75

3.9

3.3

45.99

46.73

u/l

0.49

17729

150299

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14576

118677

1.50

218.10

3.7

3.2

112.66

119.90

ug/l

2.75

13653

111073

(36304419) Bacteria [Presence] in Urine

8911

65558

1.54

217.29

4.0

3.2

57.49

179.54

estimate

0.54

298

(3005719) IgG [Mass/volume] in Serum or Plasma

3282

18819

1.85

209.49

3.0

2.9

10.27

10.56

g/l

3.52

3024

17443

(3044889) 12 lead EKG panel

18817

162157

1.53

208.97

4.9

4.0

0.41

2394.41

1.18

319

(3023368) Bacteria identified in Blood by Culture

8933

66248

1.52

207.45

4.8

4.3

—

(3015736) pH of Urine

13058

104619

1.48

207.32

4.2

3.5

6.27

6.23

3.04

7139

57808

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2049

10016

2.13

207.17

1.9

2.0

39.30

39.65

u/l

0.34

1842

8926

(3035350) Ketones [Presence] in Urine by Test strip

15750

131001

1.48

206.66

4.8

3.9

6.54

3.84

estimate

0.82

3050

27828

(3009261) Glucose [Presence] in Urine by Test strip

15834

131923

1.48

205.36

4.8

4.0

0.37

0.23

estimate

0.15

2880

26427

(3021601) Nitrite [Presence] in Urine by Test strip

15561

129483

1.48

201.02

4.8

3.9

0.00

estimate

1.14

2983

27190

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7985

58311

1.52

197.03

1.4

1.3

1.84

1.63

u/ml

0.54

1939

15816

(3007164) IgA [Mass/volume] in Serum or Plasma

7084

50441

1.55

196.22

1.6

1.5

2.24

2.38

g/l

8.50

4218

31166

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3222

18787

1.81

193.68

2.7

2.3

7.09

7.20

ug/l

0.10

2799

16448

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4636

29921

1.66

193.58

2.0

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

23620

215936

1.74

193.01

7.2

6.3

39.12

39.04

mmol/mol

0.66

22333

202449

(3023410) Appearance of Cerebral spinal fluid

760

2370

3.27

192.95

1.5

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6215

43169

1.57

191.43

3.7

3.0

0.98

1.20

e6/l

1.46

3439

22742

(3037522) Nuclear Ab [Titer] in Serum

5206

34707

1.62

190.68

1.5

1.4

508.98

522.20

titre

0.21

1096

7419

(3036489) Thrombin time

1864

9085

2.13

189.34

2.4

2.1

20.82

21.10

0.99

1636

8030

(3000850) Epithelial cells [#/volume] in Urine

7532

54694

1.52

189.22

3.2

2.7

5.36

5.92

e6/l

3.50

6912

49687

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10406

81035

1.46

183.28

3.6

3.3

31.57

33.44

u/l

1.09

9880

76481

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6457

45617

1.55

183.05

1.4

1.3

34.54

35.05

iu/ml

0.04

1835

13753

(3020564) Creatinine [Moles/volume] in Serum or Plasma

25933

245205

2.42

182.79

28.1

20.4

77.32

76.33

umol/l

4.63

25762

242382

(3019977) pH of Arterial blood

4315

27806

1.66

179.87

8.2

7.7

7.42

0.56

2424

14987

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4306

27795

1.65

178.13

8.2

7.7

5.06

5.09

kpa

0.89

4126

26787

(3027801) Oxygen [Partial pressure] in Arterial blood

4303

27783

1.65

177.78

8.1

7.7

12.85

12.47

kpa

4.51

4128

26763

(3003396) Base excess in Arterial blood by calculation

4273

27585

1.65

176.52

8.1

7.6

0.93

0.92

mmol/l

0.06

3536

22824

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

23938

221002

1.73

171.36

5.8

5.1

5.91

5.90

mmol/l

0.31

22310

204101

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4315

28157

1.63

170.17

2.1

1.8

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

23925

221015

1.72

168.73

20.6

15.4

81.95

81.85

ml/min/173m2

0.30

22483

203375

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25743

243631

2.19

164.64

15.5

12.0

25.70

25.90

u/l

0.89

25202

236869

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

597

1773

3.42

163.80

1.3

1.92

2.16

mmol/l

4.69

547

1663

(3011397) Hemoglobin [Presence] in Urine by Test strip

7962

59870

1.47

163.22

4.6

3.8

0.28

0.29

0.02

562

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

13745

114330

1.41

160.66

3.1

2.8

—

estimate

—

(3048689) Calprotectin [Mass/mass] in Stool

4840

32917

1.57

159.34

2.4

124.45

130.43

ug/g

0.39

3811

26089

(40768797) Stomach Pathology biopsy report

4901

33493

1.57

157.78

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5618

39581

1.53

157.52

3.8

3.1

3.31

3.03

e6/l

0.92

2818

19073

(3044640) Blood type and Crossmatch panel - Blood

10028

79573

1.41

150.17

2.7

2.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3592

23077

1.64

148.92

9.0

8.4

121.71

120.81

g/l

1.93

3499

22569

(3019309) Folate [Moles/volume] in Red Blood Cells

5642

40193

1.51

148.89

1.8

1125.56

1163.78

nmol/l

2.43

4356

30527

(3016502) Oxygen saturation in Arterial blood

3795

24736

1.62

148.39

8.6

8.0

95.95

95.60

2.73

3667

23897

(40758558) Short blood count panel - Blood

9348

73464

1.42

147.04

7.1

6.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5869

42290

1.50

146.12

1.4

1.3

10.00

11.59

u/ml

0.89

2036

16538

(3013247) Albumin in CSF/Albumin in Serum or Plasma

262

454

5.82

143.41

1.1

7.00

6.92

mg/g

0.03

251

434

(3022948) Iron [Moles/volume] in Serum or Plasma

5945

43100

1.49

143.14

2.9

2.6

13.01

13.08

umol/l

0.31

5529

40171

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4704

32478

1.54

142.94

6.6

6.0

1.04

mmol/l

0.04

4402

30218

(3026782) Osmolality of Urine

6341

46647

1.47

141.53

3.4

3.0

527.95

530.05

mosm/kgh2o

0.32

5646

40834

(3014051) Protein [Presence] in Urine by Test strip

8954

70292

1.41

139.83

3.5

3.0

0.05

0.07

0.40

138

1615

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6488

48255

1.45

135.78

2.8

3.0

2.44

2.45

mmol/l

8.05

5794

43242

(3013512) EKG study

10011

80413

1.39

135.30

4.2

3.6

0.70

0.74

0.17

191

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

7826

60313

1.42

134.57

2.7

2.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

654

2309

2.88

133.66

1.6

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3368

21928

1.61

130.94

8.5

7.6

1.26

1.34

mmol/l

5.36

3302

21504

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5535

40185

1.47

130.46

2.8

2.6

2.36

2.34

g/l

1.44

5099

37117

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3537

23340

1.59

129.91

2.9

2.5

45.19

47.25

u/l

0.07

3011

19769

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

560

1851

3.07

128.73

2.7

2.4

17.87

19.75

nmol/l

3.90

540

1751

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5142

36974

1.48

126.73

2.9

2.7

22.24

22.48

0.65

4764

34354

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

23125

214716

1.53

126.13

4.8

4.2

1.28

1.27

mmol/l

1.62

21544

198428

(36660697) Celiac disease serology panel - Serum

3169

20508

1.62

125.95

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

24435

230146

1.64

121.06

6.6

5.7

2.61

2.71

mmol/l

59.90

23047

215044

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

140

146

9.63

119.93

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2805

17916

1.63

117.02

1.8

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

24141

227006

1.59

116.85

5.8

5.0

4.51

4.63

mmol/l

74.64

22807

212877

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4077

28392

1.51

116.39

2.8

7.01

8.49

umol/l

5.27

3527

24740

(3007461) Platelets [#/volume] in Blood

26191

252251

2.23

115.85

33.8

24.2

251.65

253.17

e9/l

3.30

25885

247085

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

854

3684

2.36

115.78

1.3

1.2

4.19

3.76

u/ml

0.27

363

1376

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

26195

252338

2.23

115.25

34.5

24.6

40.18

40.58

5.53

26056

249675

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1446

7658

1.94

115.11

2.7

2.4

96.10

92.75

7.03

1379

7371

(3035941) MCH [Entitic mass]

26193

252319

2.23

115.10

33.6

24.0

30.28

30.27

0.41

26058

249744

(3010813) Leukocytes [#/volume] in Blood

26197

252382

2.23

114.94

33.8

24.2

6.78

6.75

e9/l

1.49

25808

246370

(3024731) MCV [Entitic mean volume] in Red Blood Cells

26192

252321

2.23

114.82

33.7

24.0

91.01

90.96

0.92

26058

249745

(3026361) Erythrocytes [#/volume] in Blood

26193

252347

2.23

114.60

33.7

24.1

4.47

4.48

e12/l

3.39

25812

246343

(3000963) Hemoglobin [Mass/volume] in Blood

26193

252398

2.22

113.68

34.0

24.3

134.19

134.66

g/l

6.44

26058

249888

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

24001

225652

1.57

113.18

5.7

4.9

1.45

1.47

mmol/l

20.94

22575

210434

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3628

24871

1.53

111.04

5.0

4.0

5.84

5.82

kpa

0.92

3538

24293

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4052

28466

1.50

110.29

4.4

235.76

243.79

u/l

2.98

3825

27024

(3012544) pH of Venous blood

3655

25174

1.52

109.28

5.1

4.0

7.38

0.04

2089

14518

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

823

3584

2.34

109.15

1.3

1.2

4.31

3.82

u/ml

0.38

427

1658

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1787

10336

1.78

107.28

1.5

1.6

12.40

14.39

iu/ml

0.20

267

(3000991) Gas panel - Venous blood

3206

21577

1.55

106.37

10.2

8.9

—

(3002032) Base excess in Venous blood by calculation

3524

24212

1.52

106.34

5.1

4.0

1.83

1.77

mmol/l

0.47

3141

21293

(3021589) Normoblasts [#/volume] in Blood

12725

108666

1.32

105.78

13.5

11.5

0.00

e9/l

0.66

10251

88620

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

179

289

6.23

105.37

2.6

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1340

7131

1.92

104.95

2.9

2.6

181.14

191.56

4.30

1274

6776

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1403

7582

1.90

104.87

1.9

1.7

0.23

g/l

0.31

1344

7225

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1433

7817

1.88

104.04

1.9

1.7

1.20

1.19

g/l

1.13

1381

7479

(3019150) Specific gravity of Urine by Refractometry

7304

57577

1.37

103.72

4.9

4.1

1.02

1.15

kg/l

1.61

5089

37869

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2509

16052

1.62

103.24

3.6

3.5

4.46

4.49

pmol/l

0.72

2273

14422

(3020630) Protein [Mass/volume] in Serum or Plasma

3040

20362

1.56

102.80

2.6

66.47

66.29

g/l

0.70

2791

18667

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2799

18431

1.58

101.96

3.4

3.0

172.81

199.18

ng/l

3.11

2557

16925

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

11608

98175

1.32

101.90

2.0

1.9

1.35

1.34

mmol/l

0.18

9957

82605

(3028026) IgM [Mass/volume] in Serum or Plasma

2341

14793

1.64

101.16

2.1

1.9

1.26

1.33

g/l

0.68

2161

13634

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2277

14319

1.64

100.27

9.9

9.6

24.32

24.29

mmol/l

0.16

2222

14007

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2212

13826

1.65

99.74

10.3

9.7

16.17

15.99

2.31

2125

13366

(3005322) IgE [Units/volume] in Serum or Plasma

2518

16280

1.60

98.98

1.4

1.3

236.50

242.22

u/ml

0.08

2342

15123

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1672

9719

1.77

98.43

1.3

0.76

0.93

u/ml

0.25

132

770

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2551

16604

1.59

97.41

9.5

8.1

24.79

24.81

mmol/l

0.10

2537

16472

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2304

14647

1.63

96.99

1.9

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

7823

62880

1.34

96.29

2.9

2.7

334.70

339.32

umol/l

3.62

6838

55517

(4268621) Lupus anticoagulant assay

628

2562

2.49

96.26

2.5

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

3051

20792

1.53

94.82

4.4

3.4

4.58

4.54

kpa

0.49

2973

20258

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2807

18849

1.55

93.26

4.1

3.9

86.35

88.76

ng/l

0.63

2482

16315

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

745

3337

2.27

92.41

1.1

119.81

117.21

1.32

686

3012

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2032

12667

1.65

92.30

1.1

27.06

6.56

u/ml

0.61

132

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1493

8573

1.78

91.48

2.3

2.2

291.03

582.81

ug/l

6.75

1419

8087

(3023420) DNA double strand Ab [Units/volume] in Serum

1735

10424

1.71

90.58

2.0

1.8

8.89

7.20

iu/ml

1.07

404

2447

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1192

6417

1.90

89.92

2.1

11.78

11.50

mg/l

0.28

1110

6007

(3009508) Creatinine [Moles/volume] in Urine

9969

83548

1.31

89.60

3.7

3.5

7.43

7.48

mmol/l

0.48

8462

70942

(3000494) Fungus identified in Specimen by Culture

4040

29414

1.44

89.59

1.6

1.5

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2405

15762

1.58

88.73

10.3

9.7

94.17

93.94

1.00

2399

15709

(4195642) Thrombophilia screening test

738

3350

2.24

88.63

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2254

14625

1.59

86.72

7.2

6.7

24.57

24.50

mmol/l

0.43

2151

14023

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1512

8849

1.75

86.64

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

3129

21861

1.49

85.64

8.2

7.4

9.08

9.81

mmol/l

7.29

2975

20910

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2384

15732

1.57

85.19

10.3

9.6

1.31

1.32

0.16

2375

15639

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2320

15236

1.57

84.65

10.6

9.9

0.64

0.11

2315

15154

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

362

1186

3.08

84.55

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2255

14731

1.58

84.16

5.3

4.2

24.33

24.19

mmol/l

1.55

2231

14556

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

309

930

3.35

83.08

1.1

707.39

372.33

ng/l

0.44

263

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

378

1286

2.97

82.65

1.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

3875

28414

1.42

81.90

2.6

1.75

1.77

0.69

3461

25343

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11370

97898

1.28

79.78

4.7

3.9

0.96

0.47

estimate

0.62

2495

22312

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1219

6865

1.81

79.51

1.5

20.81

14.20

iu/ml

0.47

158

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

21013

195649

1.33

78.77

26.8

19.4

13.62

13.61

0.51

20859

193096

(3042936) Bacteria identified in Isolate by Culture

4553

34527

1.38

78.75

2.2

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1222

6923

1.80

78.12

2.3

2.0

4.02

9.98

iu/l

1.15

502

2819

(3045414) Leukocytes [Presence] in Urine

3303

23739

1.45

77.53

2.3

2.1

0.02

estimate

0.34

593

4859

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

734

3512

2.12

77.18

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1490

8978

1.70

76.63

2.2

1.7

330.89

306.34

mu/l

0.57

1371

8137

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

333

1102

3.05

76.48

1.2

1.3

57.00

66.51

0.90

119

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2687

18685

1.49

74.60

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2225

14942

1.53

72.94

4.4

3.3

130.32

128.88

g/l

2.40

2151

14536

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1330

7888

1.72

72.42

1.6

1.5

12.22

7.38

iu/ml

0.21

232

1512

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1289

7586

1.73

72.16

1.3

33.69

41.55

u/ml

0.42

420

(3047181) Lactate [Moles/volume] in Blood

1219

7081

1.76

71.45

6.0

5.6

1.27

1.31

mmol/l

0.78

1093

6270

(3014148) Varicella zoster virus Ab [Titer] in Serum

683

3275

2.11

71.41

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

3049

21901

1.44

71.35

2.5

2.6

69.01

69.46

e9/l

0.28

2251

16019

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

567

2542

2.26

70.17

1.1

96.65

95.44

0.49

538

2377

(3012516) Albumin [Mass/volume] in Urine

9078

76875

1.27

70.00

3.6

3.5

45.86

48.42

mg/l

0.45

5734

48693

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

333

1164

2.88

69.40

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

418

1646

2.56

69.08

2.6

2.7

238.41

229.92

e6/l

0.36

349

1380

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6184

49981

1.31

68.32

1.8

1.7

44093722.10

31949957.72

pmol/l

0.69

5189

41600

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1666

10710

1.59

66.03

5.5

4.9

1.67

1.62

0.85

1568

10187

(3022145) Colonoscopy Study observation

3722

28034

1.38

65.86

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1541

9745

1.62

65.39

5.7

5.1

0.89

0.88

0.50

1450

9244

(3011412) CD3 cells [#/volume] in Blood

512

2273

2.28

64.88

2.5

2.4

1294.40

1174.91

e6/l

2.37

440

1981

(46235355) HIV 1 and 2 tests - Meaningful Use set

5895

47621

1.30

64.78

2.1

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

9157

78242

1.26

63.78

4.3

4.2

7.95

8.74

mg/mmol

0.91

5604

48468

(3019225) pH of Specimen

3080

22586

1.41

63.72

4.6

4.2

7.37

7.36

1.07

2248

16110

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1255

7583

1.69

63.66

3.3

2.6

3.48

3.58

g/l

1.97

1200

7254

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1378

8547

1.65

63.18

2.3

2.2

9.93

10.14

g/l

1.08

1237

7577

(3017732) Neutrophils [#/volume] in Blood

4037

31001

1.36

62.92

3.3

3.1

4.51

4.52

e9/l

0.01

3428

26831

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1548

9891

1.60

62.87

2.3

3.57

3.73

g/l

4.87

1417

9017

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1072

6235

1.75

62.46

1.3

30.10

10.92

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1548

9913

1.60

62.27

2.3

4.20

4.23

g/l

0.66

1419

9036

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1549

9928

1.59

62.08

2.3

7.27

7.41

g/l

2.73

1419

9039

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1908

12825

1.52

61.89

4.1

3.0

1.26

1.24

0.36

1894

12773

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1182

7089

1.70

61.62

1.3

8.81

7.64

u/ml

0.26

159

1037

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1891

12707

1.52

61.40

4.1

2.9

0.62

0.10

1881

12670

(3023511) Choriogonadotropin [Units/volume] in Urine

894

4953

1.83

61.37

1.5

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

20848

195733

1.28

61.25

28.7

20.2

332.21

332.19

g/l

0.08

20761

194648

(3017143) Hepatitis C virus Ab [Presence] in Serum

3819

29197

1.36

61.08

1.8

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1471

9367

1.60

60.56

2.3

2.84

2.90

g/l

1.72

1341

8477

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2476

17609

1.45

60.52

1.3

1.2

129.24

139.80

u/ml

0.71

929

6572

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

174

441

3.96

60.52

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

978

5594

1.78

60.37

1.3

1.2

44.69

45.19

u/ml

0.03

506

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1185

7159

1.69

60.10

1.4

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1178

7107

1.69

60.05

1.3

10.24

4.98

u/ml

0.93

108

676

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1234

7544

1.67

59.81

1.5

1.4

289.00

271.78

ug/g

1.39

706

4378

(3029937) Albumin [Presence] in Urine by Test strip

8453

71982

1.25

59.53

5.1

4.1

0.00

estimate

0.81

2822

25202

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1026

5985

1.74

59.13

1.3

5.95

4.61

u/ml

0.20

413

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

390

1611

2.44

58.28

2.6

2.5

496.35

517.29

e6/l

0.39

312

1278

(3009466) Valproate [Moles/volume] in Serum or Plasma

638

3234

2.00

57.35

4.8

5.3

354.47

361.84

umol/l

0.58

561

2813

(3039000) Anion gap in Blood by calculation

851

4775

1.81

56.02

7.0

6.7

11.10

11.26

mmol/l

0.73

765

4314

(3018572) Chloride [Moles/volume] in Blood

851

4776

1.81

55.98

7.0

6.7

105.22

105.03

mmol/l

0.50

765

4316

(3052851) Hemolysis interference index of Serum or Plasma

1106

6709

1.68

55.18

3.4

3.2

2.14

2.23

index

0.16

597

3399

(1175426) CD3 cells/Lymphocytes in Blood

422

1851

2.30

55.07

2.2

73.71

72.61

0.78

407

1780

(3024928) Oxygen saturation in Venous blood

1029

6129

1.71

54.97

4.5

3.2

61.89

61.62

0.14

993

5916

(3025941) Bacteria identified in Stool by Culture

1924

13320

1.48

53.81

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1065

6447

1.68

53.54

1.2

4.06

4.01

0.05

100

876

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2693

19868

1.39

53.15

2.9

2.5

0.36

0.42

e6/l

1.30

2571

18990

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

225

735

3.08

53.00

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

336

1355

2.50

52.92

1.7

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3503

26979

1.34

52.67

8.4

6.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

403

1772

2.29

52.31

2.1

14.61

14.89

0.21

393

1728

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1330

8571

1.58

51.90

2.4

0.77

0.82

g/l

0.21

1169

7338

(3024980) IgG subclass 4 [Mass/volume] in Serum

748

4162

1.82

50.62

1.8

1.6

0.80

0.75

g/l

0.52

585

3241

(3006245) CD3-CD19+ cells/cells in Blood

268

990

2.72

50.46

2.5

2.4

9.03

10.70

1.15

246

933

(3000060) B lymphocytes [#/volume] in Blood

221

743

2.99

49.54

2.3

0.56

0.39

e9/l

0.17

364

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2261

16387

1.41

49.30

4.1

3.9

5.11

5.14

kpa

0.88

2154

15638

(3013139) Helicobacter pylori Ag [Presence] in Stool

2337

17060

1.40

48.87

1.3

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1148

7251

1.61

48.73

2.2

2.3

0.03

g/l

0.09

1056

6499

(3019230) Fractional oxyhemoglobin in Venous blood

879

5187

1.72

48.56

4.5

2.9

62.41

61.82

0.34

874

5169

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1201

7705

1.58

47.73

3.9

3.2

0.36

0.35

iu/ml

0.32

667

4250

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1105

6959

1.61

47.46

2.3

0.00

g/l

0.76

992

6073

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1960

13941

1.44

47.38

4.0

3.8

1.47

1.78

mmol/l

3.36

1413

10276

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1045

6498

1.63

47.27

2.3

0.00

g/l

-0.00

991

6057

(4024509) Urine culture

1638

11284

1.48

46.78

2.2

1.9

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

548

2834

1.95

46.54

1.7

1.8

1717.65

2520.00

titre

0.49

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3092

23789

1.34

46.35

2.4

2.3

0.21

g/l

2.86

2879

22223

(3009343) pH of Capillary blood

2189

15941

1.41

46.31

4.2

3.9

7.41

7.42

1.33

1858

13226

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2464

18312

1.38

46.18

2.7

2.2

12.42

12.49

nmol/l

0.15

2226

16514

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1044

6555

1.62

45.39

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1049

6596

1.61

45.33

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

638

3503

1.84

45.10

1.2

21.46

14.26

u/ml

0.39

152

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

257

986

2.62

44.96

2.6

2.4

56.02

51.42

umol/l

1.28

227

853

(42529406) Shigella sp [Presence] in Stool by Culture

1046

6610

1.61

44.28

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

343

1514

2.28

44.20

1.1

0.77

1.08

—

(3008898) HLA-B27 [Presence]

1273

8468

1.53

43.00

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1629

11396

1.46

42.91

1.8

1.7

1.51

1.53

g/l

0.32

1407

9793

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

539

2870

1.90

41.98

1.9

1.7

375.43

364.78

mu/l

0.18

451

2300

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

178

582

3.07

41.97

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4929

40770

1.26

41.94

1.8

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1484

10242

1.48

41.90

2.7

2.3

5105.05

6049.39

u/l

0.51

514

4031

(3045424) Erythrocytes [Presence] in Urine

1708

12125

1.44

41.57

2.3

2.1

0.01

0.17

estimate

1.05

467

3853

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1273

8529

1.52

41.56

2.1

1.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

378

1780

2.14

41.56

2.3

2.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

172

559

3.09

40.99

1.1

—

(3020891) Body temperature

1583

11129

1.45

40.57

5.2

4.5

36.90

36.91

°c

0.46

1567

11026

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

176

584

3.03

40.47

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

495

2597

1.92

40.34

1.6

1.4

6.37

6.76

g/l

1.78

380

1869

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1111

7285

1.55

40.05

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1118

7345

1.54

39.96

1.6

1.4

10.42

10.34

u/l

0.06

871

5898

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

796

4820

1.67

39.95

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

796

4820

1.67

39.95

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

493

2596

1.92

39.74

1.6

1.4

0.35

0.41

g/l

3.77

377

1867

(3028192) IgG subclass 2 [Mass/volume] in Serum

493

2597

1.92

39.69

1.6

1.4

2.94

2.90

g/l

0.15

378

1874

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

240

950

2.54

39.45

2.3

2.2

27.74

29.31

1.01

230

910

(3028707) Methadone [Presence] in Urine by Screen method

738

4396

1.70

39.40

3.4

2.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

474

2472

1.93

39.33

1.5

1.7

—

(4062490) Immunoglobulin typing, IgG

485

2551

1.92

39.23

1.6

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

171

573

3.00

38.68

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

209

781

2.69

38.61

2.4

2.6

0.99

1.23

ug/l

1.19

204

741

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

163

532

3.08

38.60

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

421

2129

1.99

38.22

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2506

19201

1.34

38.19

2.9

2.7

66.71

66.43

ml/min/173m2

0.13

1103

8046

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

306

1381

2.23

37.47

1.4

1.5

5.70

5.98

u/l

0.16

252

1192

(3048929) Epstein Barr virus Ab [Presence] in Serum

1217

8280

1.49

36.85

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

411

2091

1.98

36.69

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1812

13290

1.39

36.46

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1336

9280

1.46

36.42

2.2

2.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

824

5154

1.62

36.38

5.8

5.6

606.52

1225.46

iu/ml

0.77

114

738

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

405

2059

1.98

36.24

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1423

10019

1.44

36.11

1.8

1.7

0.28

0.30

mg/l

0.67

616

4662

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

393

1984

2.00

35.88

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

453

2401

1.90

35.84

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

403

2056

1.97

35.71

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

586

3367

1.76

35.65

2.0

2.1

5.40

9.63

titre

0.64

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3523

28526

1.27

35.27

1.9

1.7

1.49

1.45

2.52

3086

25097

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

612

3572

1.73

35.23

1.3

0.26

0.23

nmol/l

0.19

234

(3041096) Erythrocytes [Presence] in Urine by Automated

7986

70351

1.19

35.19

4.0

3.4

0.28

0.26

estimate

0.05

2459

21813

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1036

6890

1.52

34.98

2.4

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

975

6405

1.54

34.84

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1279

8888

1.46

34.77

4.5

4.2

24.58

24.84

mmol/l

2.73

1182

8206

(3027273) Bicarbonate [Moles/volume] in Venous blood

1501

10745

1.42

34.75

4.6

3.5

25.24

25.26

mmol/l

0.09

1447

10413

(3010838) Calcium [Moles/time] in 24 hour Urine

722

4421

1.65

34.72

1.8

1.9

5.10

5.02

mmol/24h

0.18

654

3932

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

392

2001

1.97

34.69

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

383

1940

1.99

34.65

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1189

8182

1.47

33.99

2.9

2.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

598

3503

1.72

33.99

1.3

3.84

1.65

nmol/l

0.44

584

3364

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

822

5232

1.59

33.76

1.3

72.97

47.14

u/ml

0.29

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

278

1260

2.22

33.74

1.1

1606.57

1509.89

miu/ml

0.71

278

1260

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

428

2279

1.89

33.42

1.5

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

777

4905

1.60

33.04

1.3

269.67

261.70

u/ml

0.29

485

3080

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1633

11972

1.39

32.87

4.9

4.0

49.59

47.49

2.89

1613

11816

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

274

1250

2.20

32.74

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

325

1585

2.06

32.69

2.8

2.6

0.76

0.68

e9/l

2.02

316

1506

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

795

5076

1.58

32.22

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

543

3147

1.74

32.09

1.3

68.44

54.37

u/ml

0.44

199

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

789

5039

1.58

31.95

1.4

23.17

23.40

u/ml

0.01

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

187

731

2.57

31.66

1.3

1.2

30.06

20.49

0.89

108

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7320

64458

1.19

31.61

5.7

5.6

2.87

3.15

ug/l

0.35

6613

58383

(3024522) Salmonella sp identified in Specimen by Organism specific culture

535

3101

1.74

31.61

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

534

3095

1.74

31.55

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

544

3171

1.73

31.50

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

294

1401

2.11

31.47

1.1

1.06

ratio

0.37

247

1157

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

644

3929

1.65

31.45

1.4

1.5

9.25

15.64

u/ml

0.79

(3018405) Lactate [Moles/volume] in Arterial blood

1095

7535

1.47

31.30

4.2

4.0

1.32

1.40

mmol/l

1.96

1079

7385

(40768443) Skin Pathology biopsy report

1536

11239

1.39

31.25

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

964

6480

1.51

30.94

1.1

4.83

6.73

eliau/ml

0.85

805

(3005988) Vibrio sp identified in Specimen by Organism specific culture

511

2949

1.75

30.67

1.5

1.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

2655

21099

1.29

30.63

4.7

4.2

0.69

0.71

0.11

878

6235

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

510

2946

1.75

30.51

1.5

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1016

6926

1.49

30.45

2.0

1.8

42.41

42.35

nmol/l

0.02

987

6762

(3022621) pH of Urine by Test strip

2497

19706

1.29

30.39

2.9

2.6

6.07

6.09

0.47

1639

13145

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

710

4478

1.60

30.33

1.3

1.2

75.00

157.50

titre

1.54

(3025468) Yersinia sp identified in Specimen by Organism specific culture

508

2938

1.74

30.27

1.5

1.4

—

(3010503) CD19 cells [#/volume] in Blood

286

1371

2.10

30.17

2.6

293.61

309.99

e6/l

0.05

279

1325

(3023323) Follitropin [Units/volume] in Serum or Plasma

1700

12717

1.36

30.13

1.5

1.4

26.08

26.59

iu/l

0.25

1419

10881

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

925

6205

1.51

29.99

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

703

4445

1.60

29.72

1.3

1.2

226.30

290.29

titre

0.42

339

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

521

3054

1.72

29.59

1.3

0.63

0.20

nmol/l

0.46

412

2364

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1170

8246

1.44

29.48

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

779

5059

1.56

29.34

2.1

1.9

191.74

196.34

pmol/l

0.62

745

4809

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1176

8304

1.44

29.33

3.6

3.3

38.98

42.69

mg/l

0.36

1014

7057

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

550

3280

1.69

29.32

7.1

6.2

11.79

11.93

mg/l

0.31

508

3020

(3023183) Ammonium ion [Moles/volume] in Plasma

794

5180

1.55

29.30

2.5

2.7

30.77

33.56

umol/l

3.57

714

4653

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

647

4027

1.62

29.20

3.4

3.0

772.90

6329.44

u/ml

1.37

236

(3034860) Kappa light chains.free [Mass/volume] in Serum

1174

8315

1.43

28.79

3.6

3.3

80.03

58.64

mg/l

0.26

1012

7064

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

455

2590

1.77

28.68

1.2

50.94

42.00

u/ml

0.34

138

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

722

4635

1.57

28.62

1.4

1.5

149.92

149.55

au/ml

0.03

204

1317

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

837

5556

1.52

28.53

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

949

6479

1.48

28.23

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1312

9536

1.40

27.75

2.1

1.9

2.19

2.10

ug/l

0.07

1134

8463

(3028679) Herpes simplex virus Ab [Presence] in Serum

271

1319

2.07

27.50

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3557

29591

1.23

27.45

2.4

2.2

—

(3025159) Blasts/Leukocytes in Blood

2665

21483

1.27

27.21

5.2

4.6

0.29

0.31

0.04

746

5434

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1294

9419

1.39

27.13

1.6

14.26

17.58

u/ml

1.04

280

2221

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3280

27126

1.24

26.70

2.3

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

272

1343

2.04

26.57

2.9

2.8

42.87

39.13

2.73

174

736

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

658

4217

1.57

26.30

1.2

1.1

18.04

15.13

au/ml

0.41

129

1011

(3017181) Myelocytes/Leukocytes in Blood

2733

22181

1.26

26.30

4.9

4.4

0.99

0.93

0.41

871

6563

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

323

1705

1.91

26.02

1.3

1.4

11.81

12.65

umol/l

1.33

306

1603

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1045

7389

1.43

25.87

3.4

3.2

3.01

4.25

ratio

0.76

592

4259

(3045716) Anion gap in Serum or Plasma by calculation

440

2566

1.73

25.53

3.3

3.0

10.51

10.81

mmol/l

0.94

434

2531

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1936

15109

1.30

25.48

2.2

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

538

3324

1.63

25.07

1.4

1.3

327.23

364.07

pmol/l

0.49

463

2838

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2271

18144

1.27

24.87

2.4

2.1

—

(3011985) Renin [Units/volume] in Plasma

572

3605

1.60

24.58

1.7

1.5

59.21

64.59

mu/l

0.26

528

3226

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

209

962

2.18

24.58

1.0

1.1

96.35

96.40

0.01

170

755

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1168

8509

1.39

24.36

3.0

24.53

24.72

mmol/l

0.99

1146

8359

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

312

1665

1.88

24.35

3.1

3.5

142.06

158.52

nmol/l

0.23

305

1640

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

156

640

2.45

23.99

3.0

3.1

2.12

1.89

ratio

0.95

147

583

(3019420) Tryptase [Mass/volume] in Serum or Plasma

276

1423

1.95

23.90

1.4

1.5

8.89

8.68

ug/l

0.04

257

1300

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

245

1214

2.03

23.76

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

112

391

2.87

23.75

1.9

1.6

1.60

1.03

nmol/l

—

(3011048) Pyruvate [Moles/volume] in Blood

127

4.50

23.71

1.5

1.2

80.37

85.50

umol/l

0.40

116

(3013005) Retinol [Moles/volume] in Serum or Plasma

234

1142

2.06

23.66

1.8

1.9

2.05

1.90

umol/l

1.62

214

1049

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

248

3.39

23.63

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

344

1912

1.81

23.59

1.3

1.16

2.15

u/ml

1.62

216

1112

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

192

869

2.22

23.56

1.2

1.3

0.31

0.30

g/l

0.74

149

712

(3020717) Zinc [Moles/volume] in Serum or Plasma

274

1421

1.94

23.34

1.6

1.5

22.82

22.69

umol/l

0.02

254

1320

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

5.95

23.34

1.1

0.04

0.05

mg/l

0.38

(44790047) Parainfluenza type 1 nucleic acid detection

508

3153

1.62

23.28

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

742

5017

1.49

23.21

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

182

812

2.25

23.13

1.2

111.48

109.91

0.34

165

730

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

237

1172

2.03

23.13

1.5

1.6

3.73

10.85

nmol/l

0.80

191

980

(44790049) Parainfluenza type 3 nucleic acid detection

507

3153

1.62

23.05

1.6

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

897

6301

1.44

23.04

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

507

3154

1.62

23.02

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

507

3154

1.62

23.02

1.6

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

174

764

2.29

22.98

3.1

3.0

29.19

28.42

umol/l

0.29

134

579

(4094501) Cardiovascular stress test using bicycle ergometer

903

6361

1.43

22.84

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

506

3156

1.61

22.74

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

249

1264

1.98

22.59

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3342

28157

1.21

22.41

5.4

4.9

33.08

32.62

1.56

2385

18930

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

311

1704

1.83

22.38

1.2

—

(3003181) Sodium [Moles/volume] in Urine

681

4560

1.51

22.34

1.5

1.4

65.95

61.71

mmol/l

1.67

564

3616

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

235

1174

2.01

22.31

3.1

2.1

154.47

129.55

umol/l

0.44

124

606

(3021440) Promyelocytes/Leukocytes in Blood

2587

21246

1.24

22.22

4.9

4.4

0.12

0.01

728

5665

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5821

51506

1.17

22.15

4.7

4.5

22.37

22.10

0.65

2753

25456

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

136

544

2.51

22.12

1.2

1.3

96.95

95.68

0.20

136

538

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

313

1725

1.82

22.11

1.2

—

(3034426) Prothrombin time (PT)

167

733

2.29

22.09

1.3

1.2

28.66

28.03

0.47

167

733

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

303

3.04

21.67

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

695

4705

1.49

21.63

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

374

2193

1.72

21.36

1.3

1.2

70.00

72.61

u/ml

0.07

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

272

3.13

21.04

1.1

—

(3037756) Immunofixation for Serum or Plasma

733

5054

1.46

20.81

1.8

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

563

3678

1.54

20.76

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

155

679

2.29

20.64

1.3

164.19

126.76

nmol/l

0.99

112

491

(3032352) Blasts [#/volume] in Cerebral spinal fluid

261

3.15

20.50

2.2

2.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

182

858

2.13

20.25

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1561

12227

1.29

19.91

1.1

192.71

188.72

titre

0.02

330

(3028433) Virus identified in Specimen by Culture

158

709

2.24

19.89

1.1

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

575

3811

1.52

19.86

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

397

2414

1.65

19.82

3.9

3.4

14.56

13.57

index

0.58

255

1340

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

415

2552

1.64

19.82

1.2

1.1

2.42

2.04

iu/ml

0.20

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

679

4659

1.47

19.78

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

609

4106

1.49

19.38

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

208

1054

1.98

19.06

1.1

8.78

12.76

u/ml

0.33

116

(3035947) Staphylolysin Ab [Units/volume] in Serum

218

1123

1.95

19.05

1.2

1.1

3.00

3.69

iu/ml

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1523

11979

1.29

18.80

1.3

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

469

3010

1.57

18.77

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

913

6676

1.38

18.66

4.4

3.8

8.53

8.37

kpa

2.21

892

6510

(3033923) Metanephrine [Moles/time] in 24 hour Urine

112

444

2.53

18.65

1.1

12.68

0.81

umol/24h

0.48

211

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

569

3817

1.50

18.58

1.2

0.67

0.98

0.62

137

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

598

4061

1.48

18.39

1.2

1.3

30.59

34.03

u/l

0.29

522

3518

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

228

1212

1.89

18.16

1.5

2.0

152.17

146.74

0.47

215

1138

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

156

725

2.16

18.06

1.1

7.27

5.21

u/ml

0.28

(3038026) Centromere Ab [Units/volume] in Serum

318

1871

1.71

18.03

1.3

1.2

44.03

59.03

u/ml

0.37

128

(3008295) Osmolality of Serum or Plasma

422

2677

1.59

17.79

1.5

281.94

278.18

mosm/kgh2o

2.61

320

2028

(3020191) Ethanol [Moles/volume] in Serum or Plasma

334

2003

1.68

17.65

1.8

1.4

1.13

1.22

promille

0.52

269

1554

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

552

3721

1.49

17.63

1.4

1.3

25.64

27.55

u/l

0.68

457

3035

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

254

1418

1.80

17.32

2.8

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

610

4220

1.46

17.10

1.6

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

419

2684

1.57

16.96

3.1

3.5

6.60

10.55

nmol/l

0.59

403

2596

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

270

2.89

16.94

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

206

1086

1.90

16.87

1.7

1.9

29.02

28.56

umol/l

0.27

195

1023

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

598

4138

1.46

16.75

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

173

862

2.01

16.69

1.4

1.2

0.25

0.43

g/l

0.63

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

167

826

2.03

16.46

1.5

1.4

617.35

726.73

mu/l

0.24

160

788

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2310

19325

1.21

16.41

4.2

3.9

1.22

1.23

mmol/l

3.73

2055

16606

(3016879) Cocaine [Presence] in Urine

1253

9795

1.29

16.23

2.8

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

423

2746

1.55

16.17

1.1

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

168

840

2.01

16.08

1.5

1.4

74.03

72.81

0.71

161

802

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

251

2.91

16.07

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

547

3754

1.47

16.01

2.1

1.8

1.68

1.72

mmol/l

0.44

535

3659

(3036603) Volume of Urine

300

1798

1.68

15.95

1.7

1.6

2093.94

1955.11

0.83

294

1752

(3023419) Bacteria identified in Sputum by Culture

460

3051

1.52

15.93

2.8

2.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

388

2486

1.57

15.73

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

143

3.57

15.66

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

230

1292

1.79

15.43

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

163

819

2.00

15.41

1.2

1.1

88.19

90.67

0.49

370

(3010421) pH of Blood

1006

7690

1.32

15.40

3.8

3.6

7.41

1.07

995

7573

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

220

3.00

15.36

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

512

3501

1.47

15.29

1.1

3.20

2.65

0.39

569

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

164

833

1.97

15.05

1.5

1.4

14.36

15.12

pmol/l

1.12

139

695

(3024666) Lithium [Moles/volume] in Serum or Plasma

237

1354

1.76

15.02

13.0

13.4

0.59

0.62

mmol/l

0.83

210

1258

(3019832) Treponema pallidum Ab [Presence] in Serum

3033

26225

1.18

14.84

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

752

5537

1.37

14.80

1.1

1.36

2.13

u/ml

2.12

427

2993

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

759

5609

1.36

14.60

1.4

1.6

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

159

808

1.97

14.59

1.3

1.1

85.65

91.29

0.83

373

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

996

7662

1.31

14.58

4.8

4.1

1.53

1.52

mg/l

0.14

904

7005

(3037121) Protein [Mass/volume] in Urine

1071

8337

1.30

14.36

3.3

3.4

412.60

481.99

mg/l

0.35

485

3784

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

242

2.81

14.11

1.1

—

(21494755) Public health laboratory ask at order entry panel

1802

21632

0.82

14.08

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

249

2.78

13.96

1.1

—

(3003694) ABO and Rh group [Type] in Blood

7716

71270

1.12

13.96

1.5

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

163

849

1.93

13.94

1.2

111.98

107.73

0.64

150

771

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

468

3206

1.47

13.90

1.5

—

(4198724) Urine methamphetamine measurement

197

1092

1.81

13.87

3.6

2.2

—

(40767503) Oxygen content in Capillary blood by calculation

693

5096

1.37

13.78

2.7

2.6

16.77

16.42

2.12

678

4991

(3034770) Mitochondria Ab [Titer] in Serum

912

6994

1.31

13.68

1.2

984.23

939.76

titre

0.06

205

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

286

2.63

13.65

1.7

1.3

62.87

50.28

1.45

133

(3000764) Benzodiazepines [Presence] in Urine

1309

10512

1.26

13.65

2.8

1.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

902

6909

1.32

13.64

1.8

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

298

1864

1.61

13.46

1.1

9.08

7.95

iu/ml

0.29

474

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

317

2013

1.58

13.44

1.2

260.00

156.87

titre

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

285

1766

1.62

13.38

1.2

1.3

77.41

80.98

0.21

128

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

3.44

13.38

1.1

—

(4035726) Immunohistochemistry procedure

2469

21164

1.18

13.35

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

317

2018

1.58

13.30

1.2

212.39

196.16

titre

0.10

344

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

337

2.47

13.29

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

686

5069

1.36

13.25

4.1

3.9

8.77

8.64

kpa

1.22

674

4941

(3012501) Base excess in Blood by calculation

682

5035

1.36

13.24

4.2

3.9

2.16

2.55

mmol/l

3.91

462

3383

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

116

3.62

13.23

1.0

1.1

3.12

3.13

u/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

199

1123

1.78

13.23

1.3

1.2

149.78

159.39

mmol/24h

0.96

199

1123

(3013290) Carbon dioxide [Partial pressure] in Blood

682

5037

1.36

13.21

4.2

3.9

5.00

kpa

0.04

670

4910

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

136

3.39

13.09

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

396

2.33

12.96

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1310

10589

1.25

12.91

2.8

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

615

4492

1.38

12.79

1.1

1.94

1.93

u/ml

0.01

344

2346

(3016244) Insulin [Units/volume] in Serum or Plasma

262

1612

1.63

12.69

3.2

23.64

25.80

mu/l

0.55

250

1523

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

160

856

1.87

12.67

1.7

1.9

39740.84

27453.25

u/ml

0.12

120

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

328

2130

1.55

12.64

2.8

—

(3027008) Opiates [Presence] in Urine

1304

10564

1.25

12.60

2.6

1.9

—

(3017704) Immunofixation for Urine

212

1237

1.72

12.57

1.9

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

401

2722

1.48

12.53

2.4

2.5

18.23

27.42

iu/ml

1.83

265

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

311

2002

1.56

12.47

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

311

2002

1.56

12.47

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

311

2002

1.56

12.47

1.5

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

209

2.83

12.40

1.1

7.91

1.68

umol/24h

0.50

209

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

444

3081

1.45

12.39

1.6

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

186

1053

1.77

12.27

50.0

39.8

7.19

7.18

ug/l

0.03

172

946

(40760888) Immunoglobulin light chains.free panel - Serum

729

5506

1.33

12.22

3.9

3.4

—

302.87

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

347

2299

1.52

12.21

4.1

3.8

—

(3017354) Segmented neutrophils/Leukocytes in Blood

383

2592

1.48

12.16

4.0

3.4

57.35

57.42

0.02

323

2223

(3002256) Pathology report gross observation

3688

32834

1.14

12.03

1.3

—

(3027944) Amphetamines [Presence] in Urine

1283

10430

1.24

12.02

2.7

1.9

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

386

2629

1.48

11.88

1.2

30.00

33.42

nmol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

907

7095

1.29

11.77

1.2

1.3

115.52

128.74

titre

0.26

689

(3018133) Calcium [Moles/volume] in Urine

109

525

2.08

11.70

1.9

2.0

2.79

2.64

mmol/l

0.29

101

479

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

317

2080

1.53

11.69

1.2

114.46

110.44

pmol/l

0.40

317

2080

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

418

2907

1.44

11.56

2.2

2.0

21.63

25.98

mg/l

1.14

142

1069

(3006184) Hemoglobin [Mass/volume] in Capillary blood

784

6032

1.31

11.54

2.3

130.54

129.30

g/l

0.70

581

4681

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

229

2.67

11.52

1.2

2.23

1.62

iu/ml

1.45

123

(3003888) Timothy IgE Ab [Units/volume] in Serum

641

4801

1.34

11.40

1.1

3.73

5.38

u/ml

3.09

354

2574

(3021901) Oxygen saturation in Capillary blood

677

5118

1.33

11.31

3.0

3.1

90.73

90.10

1.61

661

4981

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

310

2.39

11.15

1.6

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

445

3155

1.42

11.09

1.6

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

126

3.26

11.03

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

122

626

1.95

11.02

1.5

1.4

—

(1616796) Gas panel - Central venous blood

719

5507

1.31

10.96

3.9

3.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

617

4626

1.34

10.92

1.1

1.02

1.12

u/ml

0.11

291

2087

(3010015) Selenium [Moles/volume] in Serum or Plasma

259

2.51

10.91

2.0

1.9

1.29

1.35

umol/l

0.71

193

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

185

2.81

10.89

1.1

1.3

0.64

0.55

iu/ml

0.19

(3020911) Cortisol [Moles/time] in 24 hour Urine

156

871

1.80

10.85

1.5

1.4

94.24

203.99

nmol/24h

1.67

156

871

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

172

990

1.74

10.78

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

215

2.65

10.69

1.1

1.0

0.03

0.04

u/ml

0.70

215

(3004809) Band form neutrophils/Leukocytes in Blood

541

3991

1.36

10.65

3.8

3.4

1.48

1.55

0.16

477

3586

(3014133) Dog dander IgE Ab [Units/volume] in Serum

530

3902

1.37

10.58

1.1

4.98

4.15

u/ml

0.28

290

1981

(3027456) Digoxin [Moles/volume] in Serum or Plasma

618

4658

1.33

10.57

3.6

3.3

0.77

0.81

nmol/l

0.88

501

3758

(3025018) Bordetella pertussis Ab [Titer] in Serum

270

1753

1.55

10.51

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

276

1804

1.54

10.43

1.5

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

294

1949

1.51

10.40

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

483

3519

1.38

10.30

2.1

2.2

6.38

7.21

umol/l

0.29

359

2579

(3017315) Amylase [Enzymatic activity/volume] in Urine

209

1285

1.63

10.26

1.3

1.2

179.01

341.62

u/l

3.94

192

1189

(3001186) Copper [Moles/volume] in Serum or Plasma

125

665

1.88

10.18

1.4

1.3

16.46

16.69

umol/l

0.23

113

574

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

665

5097

1.31

10.12

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2719

23991

1.15

10.03

3.8

3.4

—

(3042517) Benzodiazepines panel - Urine

291

2.34

9.82

2.8

2.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

239

1535

1.56

9.80

1.3

76.67

60.00

titre

0.37

111

(3008536) Aspergillus sp Ab [Presence] in Serum

466

2.04

9.79

1.9

2.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1024

8314

1.24

9.77

1.3

199.70

223.24

miu/ml

1.38

450

3831

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

244

1577

1.55

9.73

1.3

674.17

479.48

titre

0.18

116

(3024316) Viscosity of Plasma

106

3.30

9.68

1.4

1.8

1.35

1.64

mpas

2.14

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

112

587

1.91

9.57

1.2

110.69

106.83

0.55

107

560

(3023430) Cat dander IgE Ab [Units/volume] in Serum

496

3674

1.36

9.57

1.1

6.16

5.05

u/ml

0.40

246

1676

(3000330) Specific gravity of Urine by Test strip

1441

12134

1.20

9.55

4.0

3.4

1.02

ratio

0.31

1295

10878

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

449

3275

1.38

9.55

1.1

0.34

0.43

u/ml

0.20

167

1042

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

238

1541

1.55

9.44

2.0

2.3

101.30

97.45

1.05

223

1446

(3044927) Protein electrophoresis panel - Urine

325

2249

1.45

9.34

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

267

2.36

9.32

3.7

3.1

42.60

41.62

umol/l

0.13

228

(3008037) Lactate [Moles/volume] in Venous blood

732

5748

1.28

9.31

3.8

3.2

1.50

1.57

mmol/l

1.06

713

5613

(3027923) C peptide [Moles/volume] in Serum or Plasma

211

1334

1.59

9.29

1.5

1.6

1.17

1.25

nmol/l

0.47

150

1008

(3016038) Potassium [Moles/volume] in Urine

253

1667

1.52

9.27

1.3

1.2

33.68

34.41

mmol/l

0.19

217

1449

(3042111) Morphology [Interpretation] in Bone marrow Narrative

524

3934

1.34

9.26

1.7

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

188

1158

1.63

9.22

2.0

2.2

18.39

40.58

umol/l

2.29

116

(44806071) Cardiolipin IgM antibody measurement

325

2.22

9.21

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

199

2.57

9.01

1.6

1.7

0.87

1.86

mg/l

1.09

138

(3028717) Thiamine [Mass/volume] in Blood

316

2.22

8.96

1.2

65.23

62.59

ug/l

0.42

316

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

1.83

1.19

mg/l

0.37

125

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

0.93

1.88

mg/l

1.63

125

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

1.42

2.88

mg/l

1.74

137

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

1.98

1.54

mg/l

0.34

142

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

1.23

2.23

mg/l

1.35

148

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

0.57

1.10

mg/l

0.99

134

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

1.95

1.99

mg/l

0.02

127

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

3.02

4.34

mg/l

0.76

126

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

194

2.58

8.94

1.6

1.65

2.64

mg/l

0.85

134

(3004451) EKG impression Narrative

210

1343

1.57

8.83

1.4

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

146

852

1.72

8.82

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

288

1971

1.47

8.80

1.1

—

(3003129) Base excess in Capillary blood by calculation

392

2840

1.39

8.73

2.2

2.3

0.26

0.59

mmol/l

0.95

369

2725

(3014271) Vancomycin [Susceptibility]

172

1053

1.64

8.68

3.0

2.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

337

2383

1.42

8.65

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

2459

1.41

8.63

4.0

3.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

342

2428

1.41

8.59

2.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4188

38285

1.11

8.57

3.2

3.3

0.74

0.78

ug/l

1.11

2854

25204

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

811

6516

1.25

8.55

1.5

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

142

832

1.71

8.47

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2820

25230

1.13

8.39

3.6

4.3

29.84

24.40

ug/l

0.25

2234

20456

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

143

842

1.70

8.38

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1030

8515

1.22

8.32

1.8

1.7

4.13

4.28

mg/l

0.15

808

6255

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

190

1205

1.58

8.31

1.6

1.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

331

2359

1.41

8.16

1.4

1.3

1.54

1.45

nmol/l

0.72

293

2128

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

189

1203

1.58

8.15

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

189

1203

1.58

8.15

1.6

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

189

1203

1.58

8.15

1.6

1.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

768

6168

1.25

8.15

1.7

1.6

11463.52

13784.82

e6/l

0.98

550

4367

(3025130) Human papilloma virus identified in Specimen

521

3987

1.31

8.12

1.7

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

233

1555

1.50

8.11

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

264

1807

1.47

8.10

1.4

1.6

21.45

24.75

u/ml

0.41

348

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

102

550

1.86

8.07

1.3

1.2

102.26

82.74

2.10

152

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

232

1552

1.50

7.99

1.3

5.05

5.09

umol/l

0.05

204

1380

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

578

4497

1.29

7.97

1.7

1.6

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

153

2.68

7.95

1.8

1.3

27.69

39.36

0.91

100

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

153

2.68

7.95

1.3

1.1

9.38

28.79

1.86

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

229

1534

1.50

7.84

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

105

3.05

7.82

5.3

4.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

132

2.81

7.81

1.2

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

3.16

7.78

1.3

1.6

0.40

0.06

u/l

0.83

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

106

586

1.81

7.77

12.6

7.6

6.03

5.94

kpa

0.54

522

(3013637) Mi-2 Ab [Presence] in Serum

116

659

1.76

7.76

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

116

659

1.76

7.76

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

116

659

1.76

7.76

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

116

659

1.76

7.76

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

764

1.70

7.72

3.4

3.1

4.97

4.93

kpa

0.16

130

764

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

412

1.97

7.66

1.2

1.5

660.00

183034.29

u/ml

—

(4146454) Self-monitoring of blood glucose

343

2488

1.38

7.65

2.9

2.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

519

1.85

7.57

1.1

1.45

5.22

u/ml

1.02

441

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

129

765

1.69

7.43

3.5

3.1

10.35

10.44

kpa

0.15

129

765

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

487

1.87

7.41

1.1

21.20

30.40

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

130

774

1.68

7.38

1.3

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

107

604

1.77

7.34

1.1

—

(3033099) Centromere Ab [Titer] in Serum

110

627

1.76

7.30

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

523

4071

1.29

7.23

1.6

1.5

0.37

0.39

nmol/l

0.22

386

3115

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

550

1.80

7.17

1.2

81.00

71.58

0.81

147

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.54

7.12

1.9

1.5

144.88

280.61

nmol/l

1.17

(40768446) Kidney Pathology biopsy report

150

936

1.61

7.10

1.9

1.7

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

328

2.05

7.07

1.7

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

514

4006

1.29

7.05

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

107

613

1.75

7.00

1.9

26.53

38.33

u/l

0.40

562

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

443

3390

1.31

6.98

1.1

3.96

3.20

eliau/ml

0.33

168

1555

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

309

2241

1.38

6.95

4.9

5.3

100.94

110.12

u/ml

0.11

101

760

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

319

2.04

6.83

1.2

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

139

861

1.62

6.80

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

139

861

1.62

6.80

1.7

2.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

3.78

6.79

1.8

1.6

294.67

323.09

nmol/l

0.07

(4015189) Microbial culture of sputum

560

1.77

6.78

1.8

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

546

1.78

6.76

2.0

1.4

0.22

0.31

mmol/l

0.40

(3042631) Mycobacterium sp identified in Specimen

407

3096

1.32

6.71

3.1

2.6

—

(3016031) Almond IgE Ab [Units/volume] in Serum

186

2.37

6.66

1.0

1.1

0.40

0.88

u/ml

0.78

109

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

655

8063

0.81

6.66

1.1

0.61

0.62

ratio

0.16

966

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

183

1214

1.51

6.65

1.3

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.15

6.53

1.9

2.4

1.64

3.54

mu/l

0.78

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

164

1068

1.54

6.50

2.4

2.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

395

1.90

6.47

1.6

102.48

110.71

ug/l

0.32

330

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

218

1507

1.45

6.46

1.3

22.56

24.29

u/l

0.22

181

1256

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

486

3810

1.28

6.41

1.1

80.50

3576.45

iu/ml

0.66

784

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

504

1.79

6.40

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

734

6032

1.22

6.39

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

876

1.59

6.37

1.7

2.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

522

1.77

6.27

13.5

7.3

5.54

kpa

0.00

522

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

246

1749

1.41

6.27

1.1

17.81

18.89

u/ml

0.14

703

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

296

2.03

6.25

11.2

9.2

0.41

0.43

umol/l

0.10

262

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

124

768

1.62

6.12

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

157

2.42

6.08

1.0

1.1

5.47

10.49

u/l

1.79

157

(3001964) Herpes simplex virus Ag [Presence] in Specimen

114

693

1.65

6.07

1.4

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

375

2864

1.31

6.06

7.1

8.3

7.29

7.40

mmol/l

0.15

302

2377

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

220

1545

1.43

6.03

1.3

99.20

91.04

u/l

0.38

186

1314

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

553

1.72

5.95

1.1

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

159

1052

1.51

5.91

2.6

2.5

25.04

202.01

ug/l

1.76

153

1001

(3020876) Protein [Mass/time] in 24 hour Urine

388

2990

1.30

5.89

2.2

2.5

1.13

1.22

g/24h

0.32

207

1743

(3001686) Cold agglutinin [Titer] in Serum or Plasma

431

1.81

5.84

1.3

87.43

431.56

titre

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

381

1.87

5.83

6.5

7.0

10.78

10.48

0.51

381

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

586

4752

1.24

5.83

2.9

1.9

0.88

0.86

nmol/l

0.22

486

4044

(3006270) Folate [Moles/volume] in Blood

249

1799

1.39

5.81

1.2

351.87

359.24

nmol/l

0.22

213

1500

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.78

5.80

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

522

1.73

5.73

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

341

1.91

5.73

1.4

1.6

117653.19

203935.82

nmol/l

0.25

280

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

4.86

5.72

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

393

1.83

5.62

6.2

6.3

5726.00

4051.11

iu/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

349

2669

1.31

5.62

1.2

65.30

64.29

u/l

0.03

303

2338

(3006462) Nitrate [Presence] in Urine

161

1081

1.49

5.60

3.2

—

(3038515) Glucose [Moles/volume] in Venous blood

587

4796

1.23

5.47

4.1

3.3

7.24

7.59

mmol/l

2.35

573

4685

(44813793) Dust mix specific IgE antibody measurement

250

1832

1.37

5.39

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

112

2.59

5.36

1.6

1.2

1.16

1.19

0.02

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

1216

1.45

5.32

1.6

1.5

1695500.00

1944297.24

iu/ml

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

180

2.22

5.32

4.2

4.5

2.50

2.23

mg/l

0.44

150

(3021367) Citalopram [Moles/volume] in Serum or Plasma

3.28

5.29

1.3

1.4

223.85

120.19

nmol/l

1.19

(3003740) Influenza virus B Ag [Presence] in Specimen

549

4473

1.23

5.27

1.2

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

330

1.88

5.26

1.0

83.49

78.90

ug/l

0.32

253

(4211845) Urine protein measurement

172

1188

1.45

5.22

3.2

3.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

113

714

1.59

5.21

1.1

91.06

8.87

u/ml

0.57

411

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

367

1.83

5.21

1.5

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

548

4474

1.23

5.17

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

218

1575

1.39

5.15

1.0

36.03

41.86

ng/l

1.60

158

1109

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

260

1933

1.35

5.13

1.1

289.08

289.42

mg/l

0.03

237

1761

(3019768) Coxiella burnetii Ab [Presence] in Serum

139

2.38

5.11

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

217

1572

1.38

5.05

1.0

797.91

736.65

ng/l

0.96

148

1095

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

321

1.87

5.03

1.1

1.0

0.00

0.33

u/ml

1.47

201

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

350

1.83

5.02

1.5

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.40

5.01

1.0

—

(21494434) Karyotype in Bone marrow

278

2096

1.33

5.01

1.3

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

114

730

1.56

4.98

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2347

25693

0.91

4.97

1.9

3.44

3.45

ratio

0.01

1782

19539

(3010375) cycloSPORINE [Mass/volume] in Blood

149

1016

1.47

4.86

27.7

30.3

114.47

116.75

ug/l

0.15

116

851

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

261

1961

1.33

4.83

1.9

1.8

4.16

3.79

mg/l

0.57

251

1874

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

367

2888

1.27

4.82

1.1

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

137

2.34

4.80

2.1

1.4

14.22

12.60

0.13

(3032057) Clostridioides difficile [Presence] in Stool

451

1.71

4.80

1.6

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

881

1.50

4.80

2.8

2.7

0.61

mmol/l

0.08

132

881

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

163

2.21

4.76

1.4

1.2

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

132

2.35

4.72

1.2

1.1

47.23

60.25

u/l

0.42

106

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

500

1.66

4.68

1.3

1.19

1.18

mmol/l

0.84

500

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

249

1868

1.34

4.67

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

359

1.78

4.65

2.1

1.3

87.72

341.05

ng/l

0.55

232

(3020123) Porphyrins [Interpretation] in Serum or Plasma

140

2.29

4.59

1.0

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

113

739

1.53

4.54

7.2

6.7

25.39

24.87

mmol/l

0.77

673

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

247

1860

1.33

4.53

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

140

958

1.46

4.52

1.1

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

729

8545

0.85

4.51

1.1

1.51

1.53

g/l

0.83

729

8539

(3026480) Teichoate Ab [Titer] in Serum

194

2.06

4.47

1.1

—

2.33

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

294

2275

1.30

4.45

1.4

8.06

8.47

mmol/l

1.20

272

2168

(3022493) Free Hemoglobin [Mass/volume] in Plasma

156

1095

1.43

4.42

6.6

3.8

136.82

1321.27

mg/l

1.87

117

787

(3013336) Amino acids [Identifier] in Serum or Plasma

2.82

4.37

1.6

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

216

1604

1.35

4.37

1.4

—

(3020491) Glucose [Moles/volume] in Blood

228

1709

1.34

4.34

1.6

1.8

7.32

6.66

mmol/l

1.99

169

1238

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

100

646

1.55

4.27

1.6

0.37

0.40

ug/l

0.28

463

(3020874) Milk IgE Ab [Units/volume] in Serum

217

1619

1.34

4.27

1.1

1.23

2.63

u/ml

1.26

572

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

490

1.63

4.27

1.1

20.44

6.10

u/ml

0.52

324

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

211

1570

1.35

4.23

1.0

381.02

335.33

ng/l

0.28

153

1129

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

515

1.61

4.21

1.0

1.1

35.34

29.91

iu/ml

0.35

515

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

190

1393

1.37

4.19

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

156

1107

1.41

4.18

1.1

9.09

9.92

u/ml

0.07

181

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

127

2.28

4.18

1.1

1.3

—

11435.43

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

147

2.18

4.13

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.53

4.12

3.8

4.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

174

2.07

4.09

1.0

0.20

0.21

u/ml

0.00

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

154

1096

1.41

4.07

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

154

1096

1.41

4.07

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

227

1722

1.32

4.01

1.5

1.4

12.38

12.94

u/l

0.65

219

1667

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1006

8856

1.14

3.98

3.0

3.6

465.38

1540.51

u/ml

2.14

853

7628

(3042733) HLA Ab [Presence] in Serum

111

749

1.48

3.91

5.1

4.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

145

2.14

3.84

1.0

1.1

0.10

1.57

u/ml

1.51

106

(3006571) Granulocytes/Leukocytes in Synovial fluid

363

2938

1.24

3.84

1.5

1.6

56.02

57.68

0.31

206

1840

(3044242) Glucose [Moles/volume] in Arterial blood

174

1280

1.36

3.80

2.1

2.0

7.94

8.11

mmol/l

0.25

174

1280

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

193

1.97

3.80

1.7

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

429

1.63

3.77

1.3

—

(3049233) Organic acids panel - Urine

3.18

3.77

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

193

1445

1.34

3.76

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

445

1.62

3.75

1.3

65.39

88.64

mu/l

0.51

325

(3035285) Chloride [Moles/volume] in Venous blood

329

2643

1.25

3.73

2.8

2.3

105.95

105.52

mmol/l

1.03

324

2623

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

102

2.35

3.72

10.3

9.0

—

(3036180) Methadone [Presence] in Urine

3.59

3.69

2.5

2.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

189

1.96

3.65

1.0

1.1

0.08

0.19

u/ml

0.57

189

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

482

1.58

3.58

1.3

1.2

127.88

50.74

mg/l

0.48

346

(3010370) Gastrin [Moles/volume] in Serum or Plasma

405

1.63

3.56

1.3

2.0

60.35

48.75

pmol/l

0.29

341

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

255

1.81

3.56

1.0

5.12

0.44

u/ml

0.48

118

(3007542) Rye IgE Ab [Units/volume] in Serum

137

2.12

3.53

1.0

1.1

0.06

0.50

u/ml

1.15

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.70

3.48

2.1

241.71

241.05

ug/l

0.00

(3035320) C reactive protein [Mass/volume] in Body fluid

252

1987

1.27

3.40

3.3

2.6

26.61

28.15

mg/l

0.26

175

1436

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

381

1.63

3.35

2.2

2.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

417

3477

1.20

3.34

1.1

1.48

1.51

g/l

0.77

388

3187

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

352

1.65

3.30

2.5

2.3

1.23

1.43

mmol/l

0.29

249

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

414

1.60

3.29

2.2

1.9

—

(4034850) Laboratory test

819

7219

1.14

3.26

11.5

10.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.58

3.20

5.8

6.9

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

272

1.73

3.19

1.0

1.1

1.14

3.53

u/ml

1.24

215

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

6.36

3.18

1.0

1.1

21.29

21.45

umol/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

283

2285

1.24

3.14

1.5

1.4

151052.73

137805.72

e6/l

0.11

181

1518

(3043410) Blood group antigens tested for on Red Blood Cells

628

1.47

3.14

1.7

1.9

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

281

1.71

3.13

1.0

0.08

2.34

u/ml

0.85

129

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.96

3.13

1.2

1.5

1.71

2.07

g/l

0.51

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

152

1.97

3.08

1.1

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

166

1.93

3.07

1.2

52.75

44.88

mg/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

176

1344

1.31

3.07

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

354

2935

1.21

3.05

1.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

276

1.70

3.04

1.0

0.03

0.76

u/ml

1.53

131

(3014599) Egg white IgE Ab [Units/volume] in Serum

200

1558

1.29

3.02

1.2

1.1

3.05

5.21

u/ml

0.38

425

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

192

1488

1.29

3.01

1.5

1.3

159.90

174.87

pmol/l

0.81

192

1488

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

126

2.06

3.01

1.0

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

133

2.03

3.00

1.5

1.8

0.81

0.73

umol/l

0.24

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

211

1.80

2.98

1.2

1.4

13.88

15.83

nmol/l

0.39

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

1501

1.29

2.96

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

514

1.50

2.96

1.2

374.17

302.00

pmol/l

0.76

367

(40765096) Chromosome analysis panel by Banding

100

703

1.42

2.95

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

419

4941

0.85

2.94

4.0

3.4

23.46

27.20

mg/l

1.52

270

3455

(3045142) Bone marrow Pathology biopsy report

331

2740

1.21

2.92

1.4

1.3

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

6.67

2.86

1.0

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

617

1.44

2.84

1.3

1.2

9.30

12.02

pmol/l

0.64

226

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1475

13557

1.09

2.78

3.2

3.6

39.49

58.96

u/ml

2.37

1420

13099

(3050794) Legionella sp Ab [Presence] in Serum

209

1.77

2.77

1.1

—

(3017569) Oxygen content in Arterial blood

169

1305

1.30

2.76

1.8

2.3

16.09

15.84

0.47

169

1305

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

180

1.83

2.76

1.1

12.33

29.61

u/ml

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

232

1.73

2.74

1.1

1.0

0.19

1.36

u/ml

1.55

166

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

579

6619

0.87

2.72

1.5

0.96

0.95

ratio

0.22

343

3991

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

579

6619

0.87

2.72

1.5

1.13

1.19

ratio

0.93

345

4018

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

191

1502

1.27

2.72

1.7

1.5

5.50

7.08

u/l

1.13

157

1190

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

568

6499

0.87

2.71

1.5

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.50

2.69

1.1

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

485

1.49

2.68

6.3

6.4

69.96

69.22

0.08

369

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1776

19120

0.92

2.67

1.7

1.6

3.40

3.46

mmol/l

1.25

1211

12945

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

334

1.59

2.66

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.17

2.66

4.7

4.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

587

5139

1.15

2.66

2.9

3.5

252.19

848.82

u/ml

2.32

528

4651

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

578

6594

0.87

2.65

1.5

1.14

1.16

ratio

0.17

342

3966

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.33

2.64

3.2

1.4

77.64

134.35

ug/l

1.10

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.14

2.64

1.4

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.12

2.63

1.3

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

343

1.58

2.63

1.2

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

496

1.47

2.61

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

146

1116

1.31

2.60

4.7

3.8

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

184

1.79

2.59

1.4

22.73

15.05

pmol/l

0.40

160

(3015076) Soybean IgE Ab [Units/volume] in Serum

179

1406

1.27

2.59

1.1

0.48

1.24

u/ml

0.94

374

(3024932) HLA-DR beta [Type]

697

1.39

2.58

1.1

—

(3024471) HLA-A [Type]

714

1.39

2.57

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

3.60

2.57

1.1

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

4.00

2.56

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

125

937

1.34

2.55

1.2

1103.85

998.42

titre

0.44

190

(3007700) Barley IgE Ab [Units/volume] in Serum

122

1.97

2.49

1.0

1.1

0.05

0.63

u/ml

1.40

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

355

3009

1.18

2.48

1.8

2.0

17.55

25.91

ug/l

5.67

347

2942

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

126

952

1.33

2.45

2.3

2.0

41.10

39.95

g/l

1.86

126

952

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

157

1223

1.29

2.45

1.3

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

157

1223

1.29

2.45

1.3

1.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.08

2.42

4.7

4.6

101600.00

521867.50

u/ml

—

(3033942) Copper [Moles/time] in 24 hour Urine

103

2.04

2.40

1.7

1.1

0.51

0.65

umol/24h

0.15

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

6.25

2.37

5.4

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

470

5388

0.87

2.36

1.5

—

(3047189) Immunofixation for 24 hour Urine

138

1063

1.30

2.36

2.0

1.8

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

282

1.60

2.35

1.0

1.1

3.53

2.70

u/ml

0.15

221

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

161

1.80

2.34

5.9

6.0

—

(3002619) Bacteria identified in Specimen by Culture

660

1.38

2.33

1.2

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

169

1.78

2.31

3.1

3.7

9.02

9.27

0.02

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

347

1.53

2.30

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

222

1.67

2.29

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

141

1094

1.29

2.29

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

106

790

1.34

2.29

2.7

2.8

103.72

154.04

au/ml

0.56

121

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

138

1769

0.78

2.27

1.6

1.5

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.22

2.27

1.0

0.03

0.09

u/ml

1.15

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

103

766

1.35

2.26

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

182

1460

1.25

2.26

6.9

7.2

17.51

75.98

ug/l

1.74

114

968

(3005033) Fetal Nuchal fold Thickness US

462

5280

0.87

2.24

1.5

1.27

1.26

0.17

329

3886

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

194

1.70

2.21

2.0

1.6

—

(3033086) Enterovirus Ab [Titer] in Serum

2.19

2.20

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

195

1.69

2.18

2.9

29.75

59.93

pmol/l

0.45

(3012565) Volume of 24 hour Urine

150

1183

1.27

2.16

2.0

2.2

1905.89

1935.86

0.16

135

1049

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

115

1.91

2.14

35.8

8.4

105.77

104.33

g/l

0.13

115

(3005011) Chlamydia sp Ab [Titer] in Serum

330

1.52

2.12

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

387

1.47

2.11

2.3

2.7

49.85

45.55

mg/l

0.05

(3043238) Trisomy 21 risk [Likelihood] in Fetus

485

5497

0.88

2.09

1.5

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

138

1083

1.28

2.09

2.1

83.65

108.52

ug/min

0.20

236

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

176

1.71

2.05

1.0

6.86

1.38

u/ml

0.59

142

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

283

2400

1.18

2.03

1.3

—

titre

—

(3041184) Isoniazid [Presence] in Urine

3.08

2.01

2.8

2.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

351

1.48

2.00

1.4

1.2

34.00

42.22

mg/l

0.82

297

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

634

5695

1.12

1.99

1.4

112.95

150.55

pmol/l

1.86

619

5548

(3020356) Listeria sp identified in Specimen by Organism specific culture

155

1.74

1.99

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

115

888

1.30

1.99

3.8

3.7

8.50

8.64

mg/l

0.07

100

712

(3041672) Baker's yeast Ab [Presence] in Serum

148

1.76

1.97

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

627

6967

0.90

1.96

1.5

63.00

62.09

ug/l

0.19

514

5856

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

171

1.70

1.95

1.1

1.0

6.46

0.63

u/ml

0.44

159

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1165

12574

0.92

1.95

1.6

969.96

1008.34

mu/l

0.59

996

10710

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

155

1245

1.25

1.95

1.7

2.2

191.75

201.69

u/l

1.80

155

1233

(3008896) Cortisol [Moles/volume] in Urine

4.55

1.94

1.2

1.0

339.20

85.64

nmol/l

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

265

1.55

1.93

1.0

0.24

0.28

u/ml

0.06

158

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.45

1.92

3.5

5.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

852

7797

1.10

1.88

1.4

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

181

1.66

1.87

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

172

1405

1.23

1.87

1.2

1.1

25.31

23.18

u/l

0.11

154

1247

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.86

1.86

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

246

2081

1.18

1.85

1.9

1.8

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

171

1398

1.22

1.85

21.6

20.3

1377.52

2090.75

nmol/l

0.53

163

1346

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

434

1.41

1.82

1.8

1.6

0.27

0.24

nmol/l

0.23

305

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.95

1.79

1.1

1.0

0.05

0.04

u/ml

0.42

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

394

1.42

1.78

1.4

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

345

1.45

1.76

1.4

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

264

1.52

1.75

1.1

293.57

288.94

u/ml

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

3.33

1.74

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

297

1.48

1.73

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

201

1.59

1.73

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.13

1.71

5.8

8.6

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.13

1.71

1.0

0.17

0.05

u/ml

0.35

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

448

1.38

1.71

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

197

1649

1.20

1.70

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

313

3591

0.87

1.69

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

449

1.38

1.69

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

449

1.38

1.69

1.3

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

171

1415

1.21

1.67

1.2

1.1

85.29

82.78

u/l

0.11

151

1259

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

204

1.57

1.64

1.1

97.00

95.69

titre

0.03

204

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

220

1.55

1.64

1.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

112

1.79

1.64

1.2

1.0

0.02

0.06

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

947

8769

1.08

1.63

1.5

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.25

1.63

1.1

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

335

1.43

1.62

4.6

5.5

57.13

41.80

ug/min

0.54

255

(3003577) Lead [Moles/volume] in Blood

189

1.59

1.62

1.2

1.4

0.45

0.18

umol/l

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

260

2244

1.16

1.58

1.3

1.4

—

(3022475) Manganese [Moles/volume] in Blood

136

1.69

1.58

1.3

0.15

0.16

umol/l

0.65

136

(3000034) Microalbumin [Mass/volume] in Urine

230

1967

1.17

1.58

3.0

56.07

48.79

mg/l

0.18

159

1410

(3000012) Reticulocyte production index

390

3472

1.13

1.52

2.0

2.2

0.95

0.90

0.99

268

2345

(3000285) Sodium [Moles/volume] in Blood

443

1.36

1.49

1.3

1.2

137.55

138.26

mmol/l

0.52

372

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.94

1.48

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

582

1.31

1.48

1.1

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

105

840

1.25

1.45

1.8

2.2

8.69

9.19

mg/l

0.42

697

(3036005) Urine sediment comments by Light microscopy Narrative

2.50

1.45

1.0

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

318

1.42

1.45

2.5

2.9

52.10

77.53

pmol/l

1.20

278

(4212803) Bone marrow aspirate examination

195

1.54

1.45

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

102

1.77

1.44

7.2

5.7

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

3.13

1.44

1.0

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.03

1.43

1.5

1.1

3.43

2.82

mmol/l

0.45

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

497

0.68

1.43

1.1

1.2

70.74

71.02

ug/l

0.01

497

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

278

1.44

1.41

1.3

1.5

—

(40761536) Microorganisms panel - Urine sediment

2081

19882

1.05

1.39

5.1

4.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

103

830

1.24

1.36

1.1

1.0

9.25

10.78

u/ml

0.26

525

(3023199) Leukocytes [#/volume] in Pleural fluid

327

2904

1.13

1.36

1.5

1939.89

3346.04

e6/l

1.54

220

2024

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

200

1.50

1.31

1.4

1.3

1.33

1.63

ml/s/173m2

0.29

131

(3025549) Creatine [Moles/time] in 24 hour Urine

184

1.52

1.31

1.2

1.4

—

14.73

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.09

1.30

1.4

1.5

500.89

403.14

mg/24h

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

157

1327

1.18

1.30

16.5

15.0

794.21

1790.80

nmol/l

0.51

151

1284

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

446

1.32

1.29

2.2

2.3

8.25

7.42

mmol/l

0.36

266

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.76

1.28

1.0

1.1

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

2.78

1.28

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

292

2588

1.13

1.27

1.4

1.5

42719.16

54968.22

e6/l

0.46

159

1445

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

235

1.45

1.26

1.1

0.24

0.69

u/ml

1.65

114

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.86

1.23

1.0

1.2

29.65

51.12

umol/24h

0.50

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

131

1.60

1.23

1.1

1.2

1.42

1.10

u/field

0.43

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.77

1.22

1.1

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

116

960

1.21

1.22

1.3

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

116

1.64

1.21

1.8

1.3

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

101

1.68

1.19

1.2

1.0

0.02

0.05

u/ml

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

117

1.62

1.17

1.4

1.3

1.28

1.79

mg/l

1.21

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.70

1.17

1.1

1.2

282.25

254.96

nmol/l

0.20

(3004446) Plasmodium sp identified in Blood by Light microscopy

256

1.41

1.17

2.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

138

1167

1.18

1.16

1.3

1.5

5.06

3.62

0.38

253

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

346

0.66

1.16

1.0

7.76

8.62

u/ml

0.09

346

(3045788) Cell count panel - Pleural fluid

264

2346

1.13

1.14

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

258

1.40

1.13

1.5

1.2

6.08

6.38

mmol/l

0.13

121

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

183

1.48

1.12

3.3

2.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

157

1824

0.86

1.12

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

528

1.27

1.12

2.2

2.5

94.30

436.80

ug/l

0.81

528

(3036670) Protein [Mass/volume] in Synovial fluid

743

1.23

1.12

1.4

1.3

43.28

39.59

g/l

2.04

378

(40762814) Titanium [Mass/volume] in Blood

379

1.32

1.11

2.2

2.5

3.04

3.58

ug/l

0.68

147

(3001488) Cow milk IgE Ab [Units/volume] in Serum

1.96

1.11

1.0

—

1.18

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

376

3417

1.10

1.09

2.6

2.8

321.06

636.97

u/ml

0.47

369

3375

(40768800) Prostate Pathology biopsy report

384

4216

0.91

1.09

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.95

1.08

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

387

0.70

1.08

4.9

5.9

9.32

8.58

mmol/l

0.65

387

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

564

5222

1.08

2.3

2.4

100.75

110.74

ug/min

0.20

331

3090

(3017509) Phencyclidine [Presence] in Urine

269

1.38

1.08

2.8

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.65

1.06

1.0

1.1

0.23

1.80

u/ml

1.20

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

632

1.23

1.04

1.5

1.8

95.21

137.69

au/ml

0.44

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.73

1.02

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

149

1286

1.16

1.01

1.4

5.61

5.67

mmol/l

0.18

144

1213

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

307

1.34

1.01

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

147

1.50

1.00

1.3

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

636

1.23

1.00

1.5

1.7

10.09

9.22

ug/l

0.76

636

(3002814) Trichinella spiralis Ab [Titer] in Serum

2.00

1.00

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.71

0.98

1.1

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

223

1.39

0.98

1.1

1.2

79.40

104.58

ug/l

0.70

140

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

109

922

1.18

0.96

2.0

1.9

—

(3024263) Appearance of Synovial fluid

138

1192

1.16

0.95

1.4

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

560

1.23

0.94

1.3

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.22

0.93

1.0

0.03

0.08

u/ml

—

(3019174) dRVVT (LA screen)

201

1.39

0.91

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.63

0.90

1.1

1.20

1.31

u/field

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.60

0.90

1.1

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.75

0.90

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

600

1.22

0.89

1.5

1.3

40.80

38.03

0.23

404

(4281824) Cell count and differential, peritoneal fluid

253

2798

0.90

0.88

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

127

1.50

0.88

1.6

1.5

483.59

521.93

nmol/l

0.12

127

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

128

1110

1.15

0.86

1.1

1.2

10.06

10.20

mm/h

0.05

128

1110

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

128

1.48

0.85

1.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

390

0.74

0.84

1.4

1.2

0.78

1.45

mmol/l

0.87

260

(3003434) Protein [Mass/volume] in Pleural fluid

356

3282

1.09

0.82

1.4

1.5

31.94

32.93

g/l

0.84

323

2983

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.69

0.82

1.0

1.2

—

mmol/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

190

1.37

0.78

1.0

1.1

15.80

17.56

iu/ml

—

(3004775) Volume in Urine collected for unspecified duration

155

1746

0.89

0.78

2.3

686.59

663.43

0.29

106

1200

(3002331) Protein [Mass/volume] in Peritoneal fluid

573

0.80

0.77

1.6

1.4

24.07

38.93

g/l

0.79

449

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

124

1085

1.14

0.76

1.8

2.80

2.48

u/ml

0.10

299

(3003329) Lymphocytes/Leukocytes in Synovial fluid

243

2212

1.10

0.76

1.4

1.5

27.79

31.43

0.79

123

1362

(40757373) Influenza virus identified in Isolate

430

1.23

0.76

1.5

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.70

0.75

1.0

1.1

4.33

2.83

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.70

0.75

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.70

0.75

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.64

0.75

1.3

1.0

6.10

16.09

mg/l

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

0.01

0.90

u/ml

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.00

0.72

2.0

2.6

—

(3025577) Chromium [Mass/volume] in Blood

150

1336

1.12

0.72

2.1

2.2

2.82

2.30

ug/l

0.44

124

1108

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.58

0.71

2.0

1.3

0.19

10.43

mg/l

—

(3016750) Collection duration of Urine

113

1286

0.88

0.69

2.3

2.2

509.19

500.09

min

0.53

963

(3018851) Theophylline [Moles/volume] in Serum or Plasma

221

1.31

0.69

2.2

1.7

42.62

47.82

umol/l

0.43

221

(3035880) pH of Pleural fluid

138

1227

1.13

0.69

1.3

7.41

0.11

104

855

(3032868) Hemoglobin electrophoresis panel in Blood

213

1.31

0.68

1.6

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1215

11706

1.04

0.67

1.6

1.7

—

(40768441) Liver Pathology biopsy report

202

1838

1.10

0.67

1.5

1.4

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.63

0.66

1.0

1.1

—

371.20

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

136

1.40

0.66

1.4

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

254

2339

1.09

0.65

1.3

6.43

6.28

mmol/l

0.43

244

2174

(3012989) Citrate [Moles/time] in 24 hour Urine

1.59

0.65

1.3

1.6

2.24

1.95

mmol/24h

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

1.72

0.64

1.2

1.0

2.06

8.34

u/ml

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

686

0.85

0.61

1.2

1.3

310.44

293.43

ug/l

0.03

368

(3041918) Cholesterol [Moles/volume] in Pleural fluid

479

0.81

0.61

1.4

1.2

1.89

1.60

mmol/l

0.52

295

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.46

0.61

1.6

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

130

1.38

0.61

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

244

2253

1.08

0.60

1.3

398.22

495.92

u/l

0.42

227

2136

(3020393) Adenovirus Ag [Presence] in Stool

307

1.24

0.60

1.7

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

165

1.33

0.60

2.4

0.60

0.68

ug/l

0.75

165

(3005532) Lymphocytes/Leukocytes in Pleural fluid

781

1.14

0.57

1.4

63.62

63.78

0.02

648

(3032641) Amino acids panel - Urine

1.67

0.56

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

239

1.26

0.55

3.5

3.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

266

1.24

0.55

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

169

1.30

0.53

2.0

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

277

1.23

0.52

1.2

6.01

5.90

mmol/l

0.32

277

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

332

1.21

0.52

1.4

1.5

6.35

13.38

1.33

171

(3026470) Cobalt [Mass/volume] in Blood

151

1379

1.10

0.51

2.1

2.2

4.19

3.57

ug/l

0.26

139

1276

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.38

0.50

1.1

1.2

—

(4133840) Spirometry

614

1.14

0.48

1.3

1.2

—

(3001729) Color of Synovial fluid

178

0.73

0.48

1.2

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

128

1.33

0.47

1.1

1.3

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

1.43

0.46

1.4

1.3

1.92

2.70

mmol/l

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

328

1.19

0.46

1.1

1.2

—

(42870560) Thyrotropin [Units/volume] in Cord blood

209

0.77

0.45

1.0

8.75

8.69

mu/l

0.02

171

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

165

1.27

0.44

3.8

5.5

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

1.45

0.44

1.6

2.6

0.09

0.14

ug/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

266

1.20

0.43

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

207

0.77

0.42

1.0

1.1

1.18

1.24

mom

0.14

207

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.56

0.42

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

378

3603

1.05

0.41

1.5

1.4

3.00

3.84

ug/l

1.46

335

3203

(3027570) Oxalate [Moles/time] in 24 hour Urine

150

1.27

0.40

2.1

1.4

331.89

313.01

umol/24h

0.14

150

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

386

4035

0.96

0.38

3.9

3.8

30.01

39.22

u/ml

1.16

376

3899

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.36

0.38

1.0

6.78

4.04

u/ml

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.35

0.37

1.2

1.1

1656.00

1797.30

titre

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

778

0.90

0.37

2.1

1.8

6417.54

12515.41

e6/l

0.77

397

(40765089) Chromosome analysis panel - Blood by G-banded

792

1.10

0.36

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

208

1.20

0.35

2.5

2.1

68.76

59.51

0.64

132

(3044007) Cell count panel - Peritoneal fluid

764

0.90

0.34

2.3

1.9

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.28

0.32

2.0

2.1

24.40

30.04

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

476

0.88

0.32

2.2

1.9

2.14

2.87

ug/l

0.50

295

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

192

1.20

0.32

1.0

1.1

3.79

8.37

u/ml

—

115

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

134

1253

1.07

0.31

1.6

1.8

1.68

2.71

u/field

2.03

877

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

323

1.15

0.31

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

123

1147

1.07

0.31

5.6

6.1

1112.59

4329.88

u/ml

0.43

185

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

201

1905

1.06

0.31

1.7

2.0

2.35

3.02

u/field

0.22

115

1042

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

193

1.19

0.30

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

176

1860

0.95

0.30

1.5

1.6

8.08

7.75

mmol/l

1.36

171

1787

(3023487) Leukocytes [#/volume] in Peritoneal fluid

901

0.92

0.29

2.1

2.0

10840.47

1701.19

e6/l

0.52

595

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

139

1.22

0.29

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

460

0.89

0.28

3.2

45.93

44.04

0.29

460

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

459

0.89

0.27

6.3

6.4

8.02

8.90

0.58

459

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

318

1.13

0.27

1.3

1.2

—

(3022670) pH of Venous cord blood

1.23

0.27

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

614

1.09

0.27

2.9

3.0

136.42

110.56

ng/l

0.48

335

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

160

1.19

0.25

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

160

1.19

0.25

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

181

0.83

0.25

1.1

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

435

1.10

0.24

1.6

1.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

247

1.13

0.22

3.4

3.1

1.79

1.15

mg/l

0.87

177

(3029612) Listeria sp Ab [Titer] in Serum

1.22

0.22

1.0

1.3

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

657

0.93

0.20

1.3

1.4

12.70

13.63

g/l

0.34

494

(44806420) Estimation of glomerular filtration rate

259

2678

0.97

0.20

2.4

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

176

1.14

0.17

2.7

2.6

—

(40768806) Pleura Pathology biopsy report

253

2457

1.03

0.17

1.4

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

417

1.08

0.16

3.0

2.7

840.05

1711.43

u/l

0.72

378

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

177

1.13

0.16

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

243

2499

0.97

0.15

1.3

1.2

—

(40760409) HLA-A [Type] by High resolution

0.79

0.14

1.0

—

(40760410) HLA-B [Type] by High resolution

0.79

0.14

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

118

0.85

0.14

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

665

1.05

0.14

1.4

57.37

55.21

0.20

573

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

237

1.10

0.14

1.5

1.2

0.61

0.40

u/ml

—

(3009677) Dengue virus Ab [Presence] in Serum

103

1.17

0.13

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

274

0.91

0.13

2.2

2.5

0.84

0.60

u/field

0.49

274

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

188

1828

1.03

0.13

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

745

0.95

0.13

2.6

3.0

—

(3046861) Legionella sp Ag [Presence] in Urine

148

0.88

0.12

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.18

0.12

1.5

1.0

349.20

209.08

pmol/l

—

(3050129) First trimester maternal screen panel - Serum or Plasma

821

8306

0.99

0.12

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

152

1.12

0.12

1.0

5.26

17.55

u/ml

2.15

126

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

173

1777

0.97

0.12

1.3

12.72

14.40

u/l

0.49

156

1635

(3044416) Complement C4 [Mass/volume] in Pleural fluid

114

1.14

0.11

1.5

1.2

0.07

g/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

126

1296

0.97

0.10

1.9

1.8

129.78

758.55

pmol/l

0.72

181

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

325

3198

1.02

0.10

1.3

7.24

7.18

mmol/l

0.14

295

2806

(46235168) Fasting glucose [Moles/volume] in Blood

281

1.07

0.09

1.2

2.1

7.62

7.75

mmol/l

0.02

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

116

1.12

0.09

1.3

1.2

—

(3013762) Body weight Measured

1.07

0.08

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

877

0.97

0.08

1.9

1.6

0.04

estimate

0.03

877

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

883

1.03

0.08

2.2

2.5

143.38

146.96

nmol/l

0.14

776

(1761482) Bacteria [#/volume] in Urine by Culture

571

5651

1.01

0.08

5.3

4.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.08

0.08

1.0

1.2

38.73

30.58

mg/24h

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.86

0.07

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

266

0.94

0.07

1.1

21.31

20.43

u/l

0.10

174

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

470

4652

1.01

0.07

1.5

59.26

60.69

ug/l

0.29

470

4652

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

608

6027

1.01

0.07

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

136

1388

0.98

0.07

1.6

1.5

35.57

35.19

nmol/l

0.04

125

1271

(3021706) Oxygen [Partial pressure] in Arterial cord blood

183

0.93

0.06

1.1

1.0

4.23

3.24

kpa

0.43

154

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

100

0.90

0.06

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

928

1.02

0.06

1.6

1.4

0.53

0.51

e9/l

0.40

928

(3023383) Lactate [Moles/volume] in Pleural fluid

709

0.97

0.06

1.3

3.33

3.45

mmol/l

0.11

656

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

131

0.92

0.05

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

129

1.09

0.05

3.3

3.7

—

(3014891) Appearance of Pleural fluid

278

1.04

0.04

1.7

1.5

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

514

0.97

0.04

1.3

1.4

25.03

22.92

0.19

435

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

111

1128

0.98

0.04

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

1.10

0.04

1.6

1.4

695.40

889.52

nmol/l

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

102

1036

0.98

0.04

3.2

1.35

1.26

0.21

102

1036

(3000919) Neutrophils/Leukocytes in Pleural fluid

608

1.02

0.03

1.5

1.4

22.65

20.92

0.22

547

(4038314) Semen analysis, post vasectomy

132

1.06

0.02

1.3

1.2

—

(40758292) HTLV I+II Ab panel - Serum

450

1.02

0.02

1.3

—

(3026726) Creatinine [Moles/volume] in Specimen

193

0.98

0.00

2.5

2.4

172.26

353.96

umol/l

1.19

185

(3001893) Eosinophils/Leukocytes in Pleural fluid

675

0.99

0.00

1.5

1.4

3.12

2.66

0.21

571

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

296

1.01

0.00

1.2

21.13

20.50

mmol/l

0.44

248

(3009871) Measles virus Ab [Titer] in Serum

937

1.00

0.00

1.7

1.6

3560.00

3354.00

titre

0.10

160

(3018834) Bilirubin.total [Presence] in Urine by Test strip

122

0.98

0.00

2.3

4.0

—

0.00

estimate

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

166

1.02

0.00

2.9

2.0

9.89

18.51

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

333

0.99

0.00

1.5

1.3

214.62

252.44

u/l

0.08

240

(40758358) Immune stain study

105

0.95

0.00

1.0

—

(3006598) pH of Arterial cord blood

187

1.02

0.00

1.1

1.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.5

—

4.00

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.7

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

0.0

1.1

—

2.44

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

1.02

-0.00

1.8

1.1

53.05

76.19

mu/l

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.91

-0.00

7.4

5.7

0.19

0.22

mmol/l

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.91

-0.00

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

392.80

—

(46236302) HLA-C [Type] by High resolution typing

0.90

-0.00

1.0

—

(40763791) Oxygen content in Venous blood by calculation

0.97

-0.00

6.8

5.0

11.57

12.02

ml/dl

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

1.00

-0.00

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

1.00

-0.00

4.0

7.3

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

7.98

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_VISUDISTURB and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_VISUDISTURB	1.19 [1.08, 1.31]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.113

During the follow-up period (1.1.1998 — 31.12.2019), 8393 out of 74214 females with H7_VISUDISTURB died.

Males

Parameter	HR [95% CI]	p-value
H7_VISUDISTURB	1.357 [1.23, 1.5]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 9442 out of 60739 males with H7_VISUDISTURB died.

Mortality risk

Mortality risk for people of age

years, who have H7_VISUDISTURB.

N-year risk	Females	Males
1	0.077%	0.284%
5	0.616%	1.577%
10	1.601%	3.993%
15	3.134%	7.248%
20	5.535%	12.138%

Relationships between endpoints

↥

Index endpoint: H7_VISUDISTURB – Visual disturbances

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Visual disturbances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints